| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 4.69e-42 | 46 | 99 | 23 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 1.72e-27 | 188 | 99 | 24 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 ANK2 MAP1A COL28A1 COL5A3 COL22A1 COL23A1 AHNAK ELN BSN COL1A2 | 1.78e-15 | 891 | 99 | 28 | GO:0005198 |
| GeneOntologyMolecularFunction | heparin binding | COL5A1 COL11A1 COL11A2 COL13A1 COL17A1 COL28A1 COL5A3 COL23A1 CHRD | 4.78e-07 | 192 | 99 | 9 | GO:0008201 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | COL5A1 COL11A1 COL11A2 COL13A1 COL17A1 COL28A1 COL5A3 COL23A1 CHRD | 7.46e-06 | 268 | 99 | 9 | GO:0005539 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 2.52e-05 | 12 | 99 | 3 | GO:0048407 | |
| GeneOntologyMolecularFunction | sulfur compound binding | COL5A1 COL11A1 COL11A2 COL13A1 COL17A1 COL28A1 COL5A3 COL23A1 CHRD | 3.28e-05 | 323 | 99 | 9 | GO:1901681 |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.19e-04 | 51 | 99 | 4 | GO:0043394 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 7.33e-21 | 377 | 96 | 24 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 7.80e-21 | 378 | 96 | 24 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 8.30e-21 | 379 | 96 | 24 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.52e-09 | 12 | 96 | 5 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 1.61e-08 | 18 | 96 | 5 | GO:0038065 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 6.38e-08 | 76 | 96 | 7 | GO:0030199 | |
| GeneOntologyBiologicalProcess | aortic valve development | 2.32e-06 | 46 | 96 | 5 | GO:0003176 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 3.53e-06 | 50 | 96 | 5 | GO:1905314 | |
| GeneOntologyBiologicalProcess | heart valve development | 3.17e-05 | 78 | 96 | 5 | GO:0003170 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle formation | 1.28e-04 | 4 | 96 | 2 | GO:0003218 | |
| GeneOntologyBiologicalProcess | skeletal system development | COL5A2 COL9A1 COL9A2 COL11A1 COL11A2 COL13A1 COL19A1 SLC10A7 HOXB2 CHRD COL1A2 | 1.35e-04 | 615 | 96 | 11 | GO:0001501 |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to microtubule | 2.12e-04 | 5 | 96 | 2 | GO:1902817 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to microtubule | 2.12e-04 | 5 | 96 | 2 | GO:1902816 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.42e-04 | 187 | 96 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 3.18e-04 | 6 | 96 | 2 | GO:1903225 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 FCN1 C1QTNF7 COL1A2 | 5.73e-39 | 88 | 96 | 25 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL11A1 COL11A2 COL28A1 COL5A3 COL1A2 | 1.44e-31 | 21 | 96 | 15 | GO:0098644 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 5.86e-21 | 332 | 96 | 23 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 FCN1 ELN COL1A2 | 1.02e-18 | 530 | 96 | 25 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 VASN COL5A3 COL22A1 COL23A1 FCN1 ELN COL1A2 | 1.31e-17 | 656 | 96 | 26 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 VASN COL5A3 COL22A1 COL23A1 FCN1 ELN COL1A2 | 1.41e-17 | 658 | 96 | 26 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.75e-16 | 8 | 96 | 7 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.75e-16 | 8 | 96 | 7 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.75e-16 | 8 | 96 | 7 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 8.01e-15 | 6 | 96 | 6 | GO:0005587 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 2.68e-14 | 12 | 96 | 7 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 2.68e-14 | 12 | 96 | 7 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL17A1 COL28A1 COL23A1 | 3.72e-13 | 122 | 96 | 12 | GO:0005604 |
| GeneOntologyCellularComponent | collagen type V trimer | 4.18e-10 | 4 | 96 | 4 | GO:0005588 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.08e-09 | 5 | 96 | 4 | GO:0005592 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL8A1 COL11A1 COL11A2 ANK2 MAP1A MAP6 PYROXD1 COL28A1 COL5A3 AHNAK SYNE2 FMN2 ELN AHNAK2 COL1A2 | 2.86e-09 | 1187 | 96 | 23 | GO:0099081 |
| GeneOntologyCellularComponent | collagen type IX trimer | 3.74e-07 | 4 | 96 | 3 | GO:0005594 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 1.86e-06 | 6 | 96 | 3 | GO:0005593 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL5A1 COL5A2 COL11A1 COL11A2 ANK2 MAP1A MAP6 PYROXD1 COL28A1 COL5A3 AHNAK SYNE2 FMN2 ELN AHNAK2 COL1A2 | 8.77e-05 | 1179 | 96 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | costamere | 1.36e-04 | 22 | 96 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 9.29e-04 | 94 | 96 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | axolemma | 4.14e-03 | 21 | 96 | 2 | GO:0030673 | |
| HumanPheno | Glomerular basement membrane lamellation | 6.44e-07 | 3 | 45 | 3 | HP:0030034 | |
| HumanPheno | Fragmentation of the metacarpal epiphyses | 6.44e-07 | 3 | 45 | 3 | HP:0009189 | |
| HumanPheno | Fragmented epiphyses of the upper limbs | 6.44e-07 | 3 | 45 | 3 | HP:0003841 | |
| HumanPheno | Radially deviated wrists | 6.44e-07 | 3 | 45 | 3 | HP:0006190 | |
| HumanPheno | Anterior lenticonus | 6.44e-07 | 3 | 45 | 3 | HP:0011501 | |
| HumanPheno | Abnormality of the epiphyses of the elbow | 6.44e-07 | 3 | 45 | 3 | HP:0003946 | |
| HumanPheno | Vitreoretinopathy | 1.01e-06 | 22 | 45 | 5 | HP:0007773 | |
| HumanPheno | Lenticonus | 1.07e-06 | 10 | 45 | 4 | HP:0001142 | |
| HumanPheno | Osteoarthritis | 1.23e-06 | 65 | 45 | 7 | HP:0002758 | |
| HumanPheno | Small epiphyses | 1.61e-06 | 24 | 45 | 5 | HP:0010585 | |
| HumanPheno | Ulnar deviated club hands | 2.56e-06 | 4 | 45 | 3 | HP:0006055 | |
| HumanPheno | Reduced arm span | 2.56e-06 | 4 | 45 | 3 | HP:0012770 | |
| HumanPheno | Fragmented epiphyses | 6.37e-06 | 5 | 45 | 3 | HP:0100168 | |
| HumanPheno | Degenerative vitreoretinopathy | 6.37e-06 | 5 | 45 | 3 | HP:0007964 | |
| HumanPheno | Limb pain | 8.73e-06 | 57 | 45 | 6 | HP:0009763 | |
| HumanPheno | Knee pain | 1.16e-05 | 17 | 45 | 4 | HP:0030839 | |
| HumanPheno | Abnormality of radial epiphyses | 1.27e-05 | 6 | 45 | 3 | HP:0003999 | |
| HumanPheno | Abnormality of lens shape | 1.49e-05 | 18 | 45 | 4 | HP:0011526 | |
| HumanPheno | Atrophic scars | 1.51e-05 | 37 | 45 | 5 | HP:0001075 | |
| HumanPheno | Fragile skin | 1.51e-05 | 37 | 45 | 5 | HP:0001030 | |
| HumanPheno | Myopia | COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 KCNH1 ELN COL1A2 | 1.72e-05 | 447 | 45 | 14 | HP:0000545 |
| HumanPheno | Abnormality of the epiphyses of the feet | 2.20e-05 | 7 | 45 | 3 | HP:0010631 | |
| HumanPheno | Uterine prolapse | 2.20e-05 | 7 | 45 | 3 | HP:0000139 | |
| HumanPheno | Glomerular deposits | 2.32e-05 | 20 | 45 | 4 | HP:0030949 | |
| HumanPheno | Genital hernia | 3.50e-05 | 8 | 45 | 3 | HP:0100823 | |
| HumanPheno | Arterial rupture | 3.50e-05 | 8 | 45 | 3 | HP:0025019 | |
| HumanPheno | Soft skin | 3.60e-05 | 44 | 45 | 5 | HP:0000977 | |
| HumanPheno | Amblyopia | 4.68e-05 | 112 | 45 | 7 | HP:0000646 | |
| HumanPheno | Arthralgia of the hip | 5.22e-05 | 9 | 45 | 3 | HP:0003365 | |
| HumanPheno | Abnormality of refraction | COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 POLR3GL KCNH1 ELN ALDH1A3 COL1A2 | 5.54e-05 | 709 | 45 | 17 | HP:0000539 |
| HumanPheno | Irregular epiphyses | 5.87e-05 | 25 | 45 | 4 | HP:0010582 | |
| HumanPheno | Abnormal vitreous humor morphology | 6.12e-05 | 49 | 45 | 5 | HP:0004327 | |
| HumanPheno | Retinal detachment | 6.55e-05 | 118 | 45 | 7 | HP:0000541 | |
| HumanPheno | Dilatation of the cerebral artery | 7.44e-05 | 51 | 45 | 5 | HP:0004944 | |
| HumanPheno | Irregular distal femoral epiphysis | 7.63e-05 | 2 | 45 | 2 | HP:0006407 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 7.63e-05 | 2 | 45 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 7.63e-05 | 2 | 45 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 7.63e-05 | 2 | 45 | 2 | HP:0006756 | |
| HumanPheno | Abnormal arm span | 1.01e-04 | 11 | 45 | 3 | HP:0012769 | |
| HumanPheno | Epiphyseal dysplasia | 1.07e-04 | 29 | 45 | 4 | HP:0002656 | |
| HumanPheno | Irregular vertebral endplates | 1.23e-04 | 30 | 45 | 4 | HP:0003301 | |
| HumanPheno | Radial deviation of the hand | 1.34e-04 | 12 | 45 | 3 | HP:0009486 | |
| HumanPheno | Thickened glomerular basement membrane | 1.34e-04 | 12 | 45 | 3 | HP:0004722 | |
| HumanPheno | Coxa valga | 1.36e-04 | 92 | 45 | 6 | HP:0002673 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.53e-04 | 94 | 45 | 6 | HP:0006500 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 1.73e-04 | 13 | 45 | 3 | HP:0033282 | |
| HumanPheno | Bilateral coxa valga | 1.73e-04 | 13 | 45 | 3 | HP:0010665 | |
| HumanPheno | Abnormal limb epiphysis morphology | 1.76e-04 | 138 | 45 | 7 | HP:0006505 | |
| HumanPheno | Pierre-Robin sequence | 2.03e-04 | 34 | 45 | 4 | HP:0000201 | |
| HumanPheno | Glomerular subepithelial deposits | 2.19e-04 | 14 | 45 | 3 | HP:0033603 | |
| HumanPheno | Postexertional symptom exacerbation | 2.19e-04 | 14 | 45 | 3 | HP:0030973 | |
| HumanPheno | Soft, doughy skin | 2.19e-04 | 14 | 45 | 3 | HP:0001027 | |
| HumanPheno | Vulvar neoplasm | 2.28e-04 | 3 | 45 | 2 | HP:0030416 | |
| HumanPheno | Subcutaneous spheroids | 2.28e-04 | 3 | 45 | 2 | HP:0025014 | |
| HumanPheno | Precordial pain | 2.28e-04 | 3 | 45 | 2 | HP:0032141 | |
| HumanPheno | Thin glomerular basement membrane | 2.28e-04 | 3 | 45 | 2 | HP:0012577 | |
| HumanPheno | Scarring | 2.41e-04 | 102 | 45 | 6 | HP:0100699 | |
| HumanPheno | Bladder diverticulum | 2.55e-04 | 36 | 45 | 4 | HP:0000015 | |
| HumanPheno | Abnormality of the vertebral endplates | 3.15e-04 | 38 | 45 | 4 | HP:0005106 | |
| HumanPheno | Small joint hypermobilty | 3.16e-04 | 69 | 45 | 5 | HP:0430046 | |
| HumanPheno | Aortic root aneurysm | 3.38e-04 | 70 | 45 | 5 | HP:0002616 | |
| HumanPheno | Abnormal patella morphology | 3.45e-04 | 109 | 45 | 6 | HP:0003045 | |
| HumanPheno | Abnormal cornea morphology | COL4A1 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL17A1 POLR3GL ZFHX2 ELN COL1A2 | 3.71e-04 | 744 | 45 | 16 | HP:0000481 |
| HumanPheno | Lower limb pain | 4.24e-04 | 41 | 45 | 4 | HP:0012514 | |
| HumanPheno | Atypical scarring of skin | 4.39e-04 | 74 | 45 | 5 | HP:0000987 | |
| HumanPheno | Spinal lipoma | 4.53e-04 | 4 | 45 | 2 | HP:6000590 | |
| HumanPheno | Cervical insufficiency | 4.53e-04 | 4 | 45 | 2 | HP:0030009 | |
| HumanPheno | Piezogenic pedal papules | 4.53e-04 | 4 | 45 | 2 | HP:0025509 | |
| HumanPheno | Genital blistering | 4.53e-04 | 4 | 45 | 2 | HP:0031464 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 4.53e-04 | 4 | 45 | 2 | HP:0010590 | |
| HumanPheno | Incisional hernia | 4.53e-04 | 4 | 45 | 2 | HP:0004872 | |
| HumanPheno | Vascular dilatation | 4.93e-04 | 215 | 45 | 8 | HP:0002617 | |
| HumanPheno | Pain | COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 MNX1 POLR3GL SYNE2 ELN CARS2 | 5.09e-04 | 846 | 45 | 17 | HP:0012531 |
| HumanPheno | Genu valgum | 5.29e-04 | 165 | 45 | 7 | HP:0002857 | |
| HumanPheno | Abnormal epiphysis morphology | COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 SLC10A7 GGCX KCNH1 COL1A2 | 6.03e-04 | 279 | 45 | 9 | HP:0005930 |
| HumanPheno | Shoulder dislocation | 6.61e-04 | 20 | 45 | 3 | HP:0003834 | |
| HumanPheno | Abnormality of upper limb joint | COL5A1 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 POLR3GL PYROXD1 SLC10A7 SYNE2 ELN COL1A2 | 6.87e-04 | 705 | 45 | 15 | HP:0009810 |
| HumanPheno | Platyspondyly | 6.90e-04 | 124 | 45 | 6 | HP:0000926 | |
| HumanPheno | Joint hypermobility | COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL11A1 COL13A1 POLR3GL PYROXD1 SLC10A7 KCNH1 ELN COL1A2 | 7.40e-04 | 557 | 45 | 13 | HP:0001382 |
| HumanPheno | Abnormal metacarpal epiphysis morphology | 7.67e-04 | 21 | 45 | 3 | HP:0005913 | |
| HumanPheno | Corneal scarring | 7.67e-04 | 21 | 45 | 3 | HP:0000559 | |
| HumanPheno | Corneal erosion | 7.79e-04 | 48 | 45 | 4 | HP:0200020 | |
| HumanPheno | Dilatation of the ascending aorta | 7.87e-04 | 84 | 45 | 5 | HP:0005111 | |
| HumanPheno | Abnormal knee physiology | 9.24e-04 | 87 | 45 | 5 | HP:0034670 | |
| HumanPheno | Abnormal corneal epithelium morphology | 9.59e-04 | 132 | 45 | 6 | HP:0011495 | |
| HumanPheno | Abnormal forearm morphology | 9.95e-04 | 239 | 45 | 8 | HP:0002973 | |
| HumanPheno | Malar flattening | 1.02e-03 | 240 | 45 | 8 | HP:0000272 | |
| HumanPheno | Pes planus | COL5A1 COL5A2 COL9A1 COL9A3 PYROXD1 SLC10A7 PRX KCNH1 ELN COL1A2 | 1.04e-03 | 365 | 45 | 10 | HP:0001763 |
| HumanPheno | Poor wound healing | 1.06e-03 | 52 | 45 | 4 | HP:0001058 | |
| HumanPheno | Increased number of skin folds | 1.12e-03 | 6 | 45 | 2 | HP:0007522 | |
| HumanPheno | Flattened epiphysis | 1.29e-03 | 25 | 45 | 3 | HP:0003071 | |
| HumanPheno | Constitutional symptom | COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 ANK2 SPI1 MNX1 POLR3GL SYNE2 ELN CARS2 COL1A2 | 1.29e-03 | 1276 | 45 | 21 | HP:0025142 |
| HumanPheno | Abnormal malar bone morphology | 1.30e-03 | 249 | 45 | 8 | HP:0012369 | |
| HumanPheno | Joint laxity | 1.31e-03 | 55 | 45 | 4 | HP:0001388 | |
| HumanPheno | High myopia | 1.31e-03 | 94 | 45 | 5 | HP:0011003 | |
| HumanPheno | Abnormal zygomatic arch morphology | 1.33e-03 | 250 | 45 | 8 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 1.33e-03 | 250 | 45 | 8 | HP:0010668 | |
| HumanPheno | Arthritis | 1.37e-03 | 251 | 45 | 8 | HP:0001369 | |
| HumanPheno | Chronic kidney disease | 1.38e-03 | 194 | 45 | 7 | HP:0012622 | |
| HumanPheno | Abnormal lens morphology | COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 POLR3GL FYCO1 KCNH1 ELN | 1.40e-03 | 837 | 45 | 16 | HP:0000517 |
| MousePheno | podocyte foot process effacement | 3.16e-06 | 38 | 85 | 5 | MP:0008140 | |
| MousePheno | hematuria | 4.60e-06 | 19 | 85 | 4 | MP:0005161 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 6.65e-06 | 44 | 85 | 5 | MP:0011348 | |
| MousePheno | hyperalgesia | 7.65e-06 | 78 | 85 | 6 | MP:0005407 | |
| MousePheno | bicuspid aortic valve | 1.46e-05 | 25 | 85 | 4 | MP:0010484 | |
| MousePheno | abnormal knee joint morphology | 1.78e-05 | 9 | 85 | 3 | MP:0030837 | |
| MousePheno | decreased thermal nociceptive threshold | 1.85e-05 | 54 | 85 | 5 | MP:0003998 | |
| MousePheno | abnormal podocyte foot process morphology | 2.02e-05 | 55 | 85 | 5 | MP:0008059 | |
| MousePheno | albuminuria | 3.93e-05 | 63 | 85 | 5 | MP:0002871 | |
| MousePheno | abnormal renal glomerular capsule morphology | 4.68e-05 | 107 | 85 | 6 | MP:0002828 | |
| MousePheno | renal cast | 5.14e-05 | 34 | 85 | 4 | MP:0011402 | |
| MousePheno | artery stenosis | 5.77e-05 | 35 | 85 | 4 | MP:0006135 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 6.55e-05 | 70 | 85 | 5 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 6.55e-05 | 70 | 85 | 5 | MP:0005326 | |
| MousePheno | abnormal aortic valve morphology | 7.50e-05 | 72 | 85 | 5 | MP:0002747 | |
| MousePheno | abnormal heart left ventricle outflow tract morphology | 7.50e-05 | 72 | 85 | 5 | MP:0010429 | |
| MousePheno | increased large unstained cell number | 8.03e-05 | 38 | 85 | 4 | MP:0012362 | |
| MousePheno | abnormal basement membrane morphology | 9.85e-05 | 40 | 85 | 4 | MP:0004272 | |
| MousePheno | perinatal lethality | COL4A1 COL5A2 COL11A1 ANK2 SPI1 MNX1 MAP6 CECR2 RXRB SH2B1 GGCX TTBK2 HOXB2 CHRD ROBO2 ALDH1A3 NOS3 COL1A2 | 1.25e-04 | 1130 | 85 | 18 | MP:0002081 |
| MousePheno | aorta stenosis | 1.39e-04 | 17 | 85 | 3 | MP:0010463 | |
| MousePheno | abnormal glomerular mesangium morphology | 1.48e-04 | 83 | 85 | 5 | MP:0011339 | |
| MousePheno | expanded mesangial matrix | 1.71e-04 | 46 | 85 | 4 | MP:0011353 | |
| MousePheno | abnormal aortic valve cusp morphology | 1.86e-04 | 47 | 85 | 4 | MP:0010595 | |
| MousePheno | abnormal glomerular capillary morphology | 1.86e-04 | 47 | 85 | 4 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 2.02e-04 | 48 | 85 | 4 | MP:0011310 | |
| MousePheno | abnormal primary polar body morphology | 2.18e-04 | 4 | 85 | 2 | MP:0012737 | |
| MousePheno | buphthalmos | 2.18e-04 | 4 | 85 | 2 | MP:0009274 | |
| MousePheno | abnormal hindlimb joint morphology | 2.30e-04 | 20 | 85 | 3 | MP:0030808 | |
| MousePheno | abnormal mesangial matrix morphology | 2.56e-04 | 51 | 85 | 4 | MP:0011338 | |
| MousePheno | abnormal heart ventricle outflow tract morphology | 2.92e-04 | 96 | 85 | 5 | MP:0010224 | |
| MousePheno | abnormal large unstained cell number | 2.97e-04 | 53 | 85 | 4 | MP:0012360 | |
| MousePheno | abnormal semilunar valve morphology | 3.07e-04 | 97 | 85 | 5 | MP:0002746 | |
| MousePheno | renal interstitial fibrosis | 3.19e-04 | 54 | 85 | 4 | MP:0003215 | |
| MousePheno | abnormal knee morphology | 3.52e-04 | 23 | 85 | 3 | MP:0030881 | |
| MousePheno | renal glomerular synechia | 3.61e-04 | 5 | 85 | 2 | MP:0011483 | |
| MousePheno | anterior polar cataract | 3.61e-04 | 5 | 85 | 2 | MP:0010259 | |
| MousePheno | vascular stenosis | 3.68e-04 | 56 | 85 | 4 | MP:0005412 | |
| MousePheno | abnormal limb joint morphology | 4.53e-04 | 25 | 85 | 3 | MP:0030805 | |
| MousePheno | abnormal blood circulation | COL4A1 COL4A2 COL4A3 COL11A2 SPI1 SZT2 GGCX CHRD ROBO2 ELN ALDH2 CARS2 NOS3 COL1A2 | 5.35e-04 | 845 | 85 | 14 | MP:0002128 |
| MousePheno | abnormal polar body morphology | 5.39e-04 | 6 | 85 | 2 | MP:0012736 | |
| MousePheno | polar cataract | 5.39e-04 | 6 | 85 | 2 | MP:0010258 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 5.71e-04 | 27 | 85 | 3 | MP:0011409 | |
| MousePheno | increased mesangial cell number | 7.07e-04 | 29 | 85 | 3 | MP:0011427 | |
| MousePheno | abnormal kidney interstitium morphology | 7.29e-04 | 67 | 85 | 4 | MP:0011425 | |
| MousePheno | podocyte hypertrophy | 7.52e-04 | 7 | 85 | 2 | MP:0011871 | |
| MousePheno | glomerulosclerosis | 7.71e-04 | 68 | 85 | 4 | MP:0005264 | |
| MousePheno | renal tubule atrophy | 7.82e-04 | 30 | 85 | 3 | MP:0011346 | |
| MousePheno | renal/urinary system inflammation | 7.90e-04 | 180 | 85 | 6 | MP:0011762 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 8.62e-04 | 31 | 85 | 3 | MP:0011349 | |
| MousePheno | perinatal lethality, incomplete penetrance | 9.25e-04 | 503 | 85 | 10 | MP:0011090 | |
| MousePheno | abnormal synovial joint morphology | 9.43e-04 | 124 | 85 | 5 | MP:0030804 | |
| MousePheno | abnormal skin tensile strength | 9.47e-04 | 32 | 85 | 3 | MP:0005275 | |
| MousePheno | macrophthalmia | 9.99e-04 | 8 | 85 | 2 | MP:0001296 | |
| MousePheno | enlarged tectorial membrane | 9.99e-04 | 8 | 85 | 2 | MP:0004591 | |
| MousePheno | abnormal kidney vasculature morphology | 1.01e-03 | 73 | 85 | 4 | MP:0000530 | |
| MousePheno | abnormal lens morphology | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 ANK2 LMCD1 ZBTB4 FYCO1 USP42 ALDH2 ALDH1A3 | 1.02e-03 | 699 | 85 | 12 | MP:0001303 |
| MousePheno | pale kidney | 1.04e-03 | 33 | 85 | 3 | MP:0004969 | |
| MousePheno | cardiac hypertrophy | 1.23e-03 | 196 | 85 | 6 | MP:0001625 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.23e-03 | 35 | 85 | 3 | MP:0031618 | |
| MousePheno | aorta hypoplasia | 1.28e-03 | 9 | 85 | 2 | MP:0010541 | |
| MousePheno | dilated glomerular capillary | 1.28e-03 | 9 | 85 | 2 | MP:0011509 | |
| MousePheno | dermal-epidermal separation | 1.28e-03 | 9 | 85 | 2 | MP:0011160 | |
| MousePheno | small geniculate ganglion | 1.28e-03 | 9 | 85 | 2 | MP:0001083 | |
| MousePheno | renal fibrosis | 1.29e-03 | 78 | 85 | 4 | MP:0003985 | |
| MousePheno | sensorineural hearing loss | 1.45e-03 | 37 | 85 | 3 | MP:0004740 | |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 FCN1 SCARA5 C1QTNF7 COL1A2 | 7.56e-40 | 85 | 99 | 26 | IPR008160 |
| Domain | Collagen | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 FCN1 SCARA5 C1QTNF7 COL1A2 | 7.56e-40 | 85 | 99 | 26 | PF01391 |
| Domain | C4 | 1.90e-14 | 6 | 99 | 6 | SM00111 | |
| Domain | - | 1.90e-14 | 6 | 99 | 6 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.90e-14 | 6 | 99 | 6 | IPR001442 | |
| Domain | C4 | 1.90e-14 | 6 | 99 | 6 | PF01413 | |
| Domain | NC1_IV | 1.90e-14 | 6 | 99 | 6 | PS51403 | |
| Domain | Fib_collagen_C | 8.60e-12 | 11 | 99 | 6 | IPR000885 | |
| Domain | COLFI | 8.60e-12 | 11 | 99 | 6 | PF01410 | |
| Domain | NC1_FIB | 8.60e-12 | 11 | 99 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 8.60e-12 | 11 | 99 | 6 | PD002078 | |
| Domain | COLFI | 8.60e-12 | 11 | 99 | 6 | SM00038 | |
| Domain | TSPN | 2.17e-11 | 23 | 99 | 7 | SM00210 | |
| Domain | Laminin_G | 2.29e-08 | 58 | 99 | 7 | IPR001791 | |
| Domain | Cadherin_tail | 1.44e-06 | 37 | 99 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 1.44e-06 | 37 | 99 | 5 | IPR031904 | |
| Domain | - | 1.13e-05 | 95 | 99 | 6 | 2.60.120.200 | |
| Domain | CTDL_fold | 2.23e-05 | 107 | 99 | 6 | IPR016187 | |
| Domain | Cadherin_2 | 2.43e-05 | 65 | 99 | 5 | PF08266 | |
| Domain | Cadherin_N | 2.43e-05 | 65 | 99 | 5 | IPR013164 | |
| Domain | Laminin_G_2 | 5.86e-05 | 40 | 99 | 4 | PF02210 | |
| Domain | LamG | 8.57e-05 | 44 | 99 | 4 | SM00282 | |
| Domain | ConA-like_dom | 1.65e-04 | 219 | 99 | 7 | IPR013320 | |
| Domain | Cadherin_CS | 2.86e-04 | 109 | 99 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 3.37e-04 | 113 | 99 | 5 | PS00232 | |
| Domain | Cadherin | 3.37e-04 | 113 | 99 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 3.51e-04 | 114 | 99 | 5 | PS50268 | |
| Domain | - | 3.51e-04 | 114 | 99 | 5 | 2.60.40.60 | |
| Domain | CA | 3.66e-04 | 115 | 99 | 5 | SM00112 | |
| Domain | Cadherin-like | 3.81e-04 | 116 | 99 | 5 | IPR015919 | |
| Domain | Cadherin | 4.12e-04 | 118 | 99 | 5 | IPR002126 | |
| Domain | - | 2.10e-03 | 48 | 99 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 2.50e-03 | 51 | 99 | 3 | IPR014710 | |
| Domain | Ald_DH_CS_GLU | 3.18e-03 | 16 | 99 | 2 | IPR029510 | |
| Domain | VWA | 3.27e-03 | 56 | 99 | 3 | PF00092 | |
| Domain | Ald_DH_CS_CYS | 3.59e-03 | 17 | 99 | 2 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 4.03e-03 | 18 | 99 | 2 | PS00687 | |
| Domain | - | 4.03e-03 | 18 | 99 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 4.03e-03 | 18 | 99 | 2 | IPR020901 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 4.03e-03 | 18 | 99 | 2 | PS00070 | |
| Domain | Ald_DH_C | 4.48e-03 | 19 | 99 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 4.48e-03 | 19 | 99 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 4.48e-03 | 19 | 99 | 2 | IPR016161 | |
| Domain | - | 4.48e-03 | 19 | 99 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 4.48e-03 | 19 | 99 | 2 | PF00171 | |
| Domain | BPTI_KUNITZ_2 | 4.48e-03 | 19 | 99 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 4.48e-03 | 19 | 99 | 2 | PF00014 | |
| Domain | Aldehyde_DH_dom | 4.48e-03 | 19 | 99 | 2 | IPR015590 | |
| Domain | - | 4.48e-03 | 19 | 99 | 2 | 3.40.309.10 | |
| Domain | BPTI_KUNITZ_1 | 4.48e-03 | 19 | 99 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 6.54e-03 | 23 | 99 | 2 | IPR002223 | |
| Domain | PDZ | 6.74e-03 | 141 | 99 | 4 | PF00595 | |
| Domain | - | 7.13e-03 | 74 | 99 | 3 | 3.40.50.410 | |
| Domain | PDZ | 7.97e-03 | 148 | 99 | 4 | SM00228 | |
| Domain | - | 8.34e-03 | 150 | 99 | 4 | 2.30.42.10 | |
| Domain | PDZ | 8.54e-03 | 151 | 99 | 4 | PS50106 | |
| Domain | PDZ | 8.73e-03 | 152 | 99 | 4 | IPR001478 | |
| Domain | VWFA | 9.45e-03 | 82 | 99 | 3 | PS50234 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 2.25e-44 | 41 | 69 | 23 | MM15538 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 2.22e-43 | 44 | 69 | 23 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 3.92e-39 | 61 | 69 | 23 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 5.44e-38 | 67 | 69 | 23 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 1.70e-36 | 76 | 69 | 23 | MM14573 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 1.50e-34 | 90 | 69 | 23 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL5A3 COL23A1 COL1A2 | 3.69e-34 | 64 | 69 | 21 | M26953 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL1A2 | 9.88e-29 | 46 | 69 | 17 | M198 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL17A1 COL5A3 COL1A2 | 2.61e-28 | 61 | 69 | 18 | M27103 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL5A3 COL1A2 | 5.48e-28 | 50 | 69 | 17 | MM14796 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL5A3 COL23A1 ELN COL1A2 | 6.17e-28 | 140 | 69 | 22 | M587 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL11A1 COL11A2 COL13A1 COL19A1 COL5A3 COL1A2 | 2.16e-25 | 53 | 69 | 16 | MM14566 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 7.53e-25 | 258 | 69 | 24 | MM14572 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL1A2 | 1.17e-24 | 74 | 69 | 17 | M160 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL13A1 COL5A3 COL23A1 COL1A2 | 1.57e-23 | 85 | 69 | 17 | M16441 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 2.89e-23 | 300 | 69 | 24 | M610 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL13A1 COL5A3 COL1A2 | 1.45e-22 | 76 | 69 | 16 | MM14867 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 2.72e-21 | 20 | 69 | 11 | MM15061 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL11A1 COL11A2 COL13A1 COL19A1 COL5A3 ELN COL1A2 | 3.31e-21 | 114 | 69 | 17 | MM14571 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 COL1A2 | 1.44e-20 | 32 | 69 | 12 | MM14924 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 1.82e-17 | 38 | 69 | 11 | MM14969 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 COL1A2 | 3.37e-17 | 76 | 69 | 13 | M27219 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 6.37e-17 | 42 | 69 | 11 | M7169 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 COL1A2 | 6.47e-17 | 59 | 69 | 12 | M27218 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.36e-15 | 15 | 69 | 8 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 2.59e-15 | 57 | 69 | 11 | MM14713 |
| Pathway | REACTOME_SIGNALING_BY_PDGF | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 3.19e-15 | 58 | 69 | 11 | M2049 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 8.46e-15 | 63 | 69 | 11 | M11187 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL4A1 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL11A1 COL11A2 COL1A2 | 1.46e-14 | 66 | 69 | 11 | M18 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.50e-12 | 18 | 69 | 7 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.50e-12 | 18 | 69 | 7 | MM14882 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.28e-12 | 10 | 69 | 6 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.28e-12 | 10 | 69 | 6 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.99e-12 | 11 | 69 | 6 | M15422 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 COL1A2 | 8.31e-12 | 84 | 69 | 10 | M7098 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 9.94e-12 | 12 | 69 | 6 | MM1526 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL5A3 SHC2 NOS3 FAM83A COL1A2 | 1.11e-11 | 418 | 69 | 17 | MM15587 |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.84e-11 | 13 | 69 | 6 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.84e-11 | 13 | 69 | 6 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.21e-11 | 14 | 69 | 6 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.21e-11 | 14 | 69 | 6 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.32e-11 | 15 | 69 | 6 | MM14922 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.17e-11 | 30 | 69 | 7 | M27216 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.84e-10 | 19 | 69 | 6 | MM15512 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 4.04e-10 | 20 | 69 | 6 | M15394 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL5A3 SHC2 NOS3 FAM83A COL1A2 | 4.79e-10 | 532 | 69 | 17 | M27870 |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.04e-09 | 23 | 69 | 6 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.04e-09 | 23 | 69 | 6 | MM1427 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.65e-09 | 47 | 69 | 7 | MM14925 | |
| Pathway | KEGG_FOCAL_ADHESION | COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 SHC2 COL1A2 | 3.00e-09 | 199 | 69 | 11 | M7253 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.96e-09 | 30 | 69 | 6 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.96e-09 | 30 | 69 | 6 | MM15517 | |
| Pathway | WP_FOCAL_ADHESION | COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 COL1A2 | 2.29e-08 | 187 | 69 | 10 | MM15913 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.33e-08 | 41 | 69 | 6 | M27778 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 5.01e-08 | 261 | 69 | 11 | MM15676 |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 5.82e-08 | 43 | 69 | 6 | M39565 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 5.82e-08 | 43 | 69 | 6 | M53 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 NOS3 COL1A2 | 2.20e-07 | 302 | 69 | 11 | M39719 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.16e-07 | 96 | 69 | 7 | M39834 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL4A1 COL4A2 COL4A4 COL4A6 COL5A1 COL5A2 COL11A1 COL11A2 COL5A3 NOS3 COL1A2 | 4.71e-07 | 326 | 69 | 11 | MM15917 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 ANK2 COL5A3 PRX ROBO2 | 5.87e-07 | 575 | 69 | 14 | M29853 |
| Pathway | WP_PI3KAKT_SIGNALING | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL9A1 COL9A2 COL9A3 NOS3 COL1A2 | 6.94e-07 | 339 | 69 | 11 | M39736 |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.69e-07 | 67 | 69 | 6 | MM15345 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.93e-06 | 19 | 69 | 4 | M27221 | |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 2.22e-06 | 6 | 69 | 3 | M39872 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.31e-06 | 79 | 69 | 6 | M27643 | |
| Pathway | WP_FOCAL_ADHESION | 5.48e-06 | 199 | 69 | 8 | M39402 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 8.47e-06 | 27 | 69 | 4 | M27217 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 COL5A3 | 2.94e-05 | 502 | 69 | 11 | MM14537 |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 5.55e-05 | 84 | 69 | 5 | M3228 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.34e-04 | 161 | 69 | 6 | M39770 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 3.37e-04 | 28 | 69 | 3 | MM15957 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL9A3 ANK2 SPI1 COL5A3 PRX HOXB2 ROBO2 | 1.24e-03 | 1432 | 69 | 16 | M509 |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.34e-03 | 98 | 69 | 4 | M27152 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.37e-03 | 45 | 69 | 3 | M39864 | |
| Pathway | WP_CANCER_PATHWAYS | 3.23e-03 | 507 | 69 | 8 | M48302 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 3.83e-03 | 19 | 69 | 2 | M48230 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 5.08e-03 | 325 | 69 | 6 | M12868 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.26e-03 | 72 | 69 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.47e-03 | 73 | 69 | 3 | MM15906 | |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A4 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL13A1 COL17A1 COL19A1 COL28A1 COL23A1 ELN COL1A2 | 4.19e-26 | 153 | 99 | 19 | 25037231 | |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A2 COL11A1 COL11A2 COL28A1 COL5A3 COL22A1 ELN COL1A2 | 3.09e-23 | 175 | 99 | 18 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL11A1 COL11A2 COL13A1 COL28A1 COL5A3 ELN COL1A2 | 9.14e-22 | 135 | 99 | 16 | 28675934 |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL4A1 COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL11A2 COL17A1 COL5A3 FCN1 COL1A2 | 2.63e-21 | 62 | 99 | 13 | 28344315 |
| Pubmed | COL4A3 COL4A6 COL5A1 COL5A2 COL7A1 COL9A1 COL9A2 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL5A3 COL23A1 CHRD COL1A2 | 1.27e-18 | 210 | 99 | 16 | 16537572 | |
| Pubmed | COL4A1 COL4A2 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL9A3 COL13A1 COL28A1 COL5A3 COL23A1 ELN COL1A2 | 1.33e-18 | 167 | 99 | 15 | 22159717 | |
| Pubmed | 4.37e-17 | 9 | 99 | 7 | 9878537 | ||
| Pubmed | 4.56e-16 | 6 | 99 | 6 | 2426947 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 4.56e-16 | 6 | 99 | 6 | 10534397 | |
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 4.56e-16 | 6 | 99 | 6 | 19275937 | |
| Pubmed | 4.56e-16 | 6 | 99 | 6 | 6988303 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 4.56e-16 | 6 | 99 | 6 | 9506531 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 4.56e-16 | 6 | 99 | 6 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 4.56e-16 | 6 | 99 | 6 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 4.56e-16 | 6 | 99 | 6 | 6389236 | |
| Pubmed | 4.56e-16 | 6 | 99 | 6 | 12225806 | ||
| Pubmed | 4.56e-16 | 6 | 99 | 6 | 10722718 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 4.56e-16 | 6 | 99 | 6 | 9673377 | |
| Pubmed | 4.56e-16 | 6 | 99 | 6 | 11732842 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 3.19e-15 | 7 | 99 | 6 | 8006028 | |
| Pubmed | 3.19e-15 | 7 | 99 | 6 | 10416788 | ||
| Pubmed | 3.19e-15 | 7 | 99 | 6 | 11711546 | ||
| Pubmed | 3.19e-15 | 7 | 99 | 6 | 1724753 | ||
| Pubmed | 3.36e-15 | 25 | 99 | 8 | 19180518 | ||
| Pubmed | 1.27e-14 | 8 | 99 | 6 | 1377218 | ||
| Pubmed | 1.27e-14 | 8 | 99 | 6 | 3997552 | ||
| Pubmed | 1.27e-14 | 8 | 99 | 6 | 29422532 | ||
| Pubmed | 1.27e-14 | 8 | 99 | 6 | 10382266 | ||
| Pubmed | 3.80e-14 | 9 | 99 | 6 | 12101409 | ||
| Pubmed | 5.98e-14 | 19 | 99 | 7 | 15689378 | ||
| Pubmed | 9.49e-14 | 10 | 99 | 6 | 9415455 | ||
| Pubmed | 9.49e-14 | 10 | 99 | 6 | 9136074 | ||
| Pubmed | 1.85e-13 | 39 | 99 | 8 | 33580754 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 2.08e-13 | 11 | 99 | 6 | 7500359 | |
| Pubmed | 2.08e-13 | 11 | 99 | 6 | 14998921 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 4.16e-13 | 12 | 99 | 6 | 15837576 | |
| Pubmed | 4.16e-13 | 12 | 99 | 6 | 16024816 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 4.16e-13 | 12 | 99 | 6 | 12180907 | |
| Pubmed | 1.01e-12 | 6 | 99 | 5 | 15922184 | ||
| Pubmed | 1.01e-12 | 6 | 99 | 5 | 7495302 | ||
| Pubmed | 1.01e-12 | 6 | 99 | 5 | 20301479 | ||
| Pubmed | 1.34e-12 | 14 | 99 | 6 | 12878203 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.48e-12 | 79 | 99 | 9 | 18757743 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 2.24e-12 | 15 | 99 | 6 | 9832566 | |
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 3.53e-12 | 7 | 99 | 5 | 10716744 | |
| Pubmed | 3.53e-12 | 7 | 99 | 5 | 7521231 | ||
| Pubmed | 3.53e-12 | 7 | 99 | 5 | 10639489 | ||
| Pubmed | 3.57e-12 | 16 | 99 | 6 | 15878328 | ||
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 ELN NOS3 COL1A2 | 6.36e-12 | 186 | 99 | 11 | 20673868 | |
| Pubmed | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 ELN NOS3 COL1A2 | 6.36e-12 | 186 | 99 | 11 | 20452482 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 9.38e-12 | 8 | 99 | 5 | 20059976 | |
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 9.38e-12 | 8 | 99 | 5 | 10970885 | |
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 9.38e-12 | 8 | 99 | 5 | 11867580 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 COL28A1 COL5A3 ELN COL1A2 | 9.83e-12 | 97 | 99 | 9 | 27559042 |
| Pubmed | 2.11e-11 | 9 | 99 | 5 | 8562707 | ||
| Pubmed | 4.20e-11 | 10 | 99 | 5 | 2446864 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 6.18e-11 | 4 | 99 | 4 | 7827955 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 7.69e-11 | 11 | 99 | 5 | 9731539 | |
| Pubmed | 1.00e-10 | 26 | 99 | 6 | 24742657 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 1.29e-10 | 27 | 99 | 6 | 12192060 | |
| Pubmed | 1.32e-10 | 12 | 99 | 5 | 8918877 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.43e-10 | 86 | 99 | 8 | 28327460 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 2.13e-10 | 13 | 99 | 5 | 36335435 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 2.13e-10 | 13 | 99 | 5 | 9833687 | |
| Pubmed | 3.08e-10 | 5 | 99 | 4 | 9409248 | ||
| Pubmed | 3.17e-10 | 31 | 99 | 6 | 22925884 | ||
| Pubmed | 3.31e-10 | 14 | 99 | 5 | 19858219 | ||
| Pubmed | 3.89e-10 | 32 | 99 | 6 | 23154389 | ||
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 4.95e-10 | 15 | 99 | 5 | 10579729 | |
| Pubmed | 4.95e-10 | 15 | 99 | 5 | 15640798 | ||
| Pubmed | 4.95e-10 | 15 | 99 | 5 | 10625553 | ||
| Pubmed | 4.95e-10 | 15 | 99 | 5 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 4.95e-10 | 15 | 99 | 5 | 10706142 | |
| Pubmed | 7.19e-10 | 16 | 99 | 5 | 17881772 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 9.22e-10 | 6 | 99 | 4 | 17029294 | |
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 9.22e-10 | 6 | 99 | 4 | 12883905 | |
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 16192629 | ||
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 21467034 | ||
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 8305476 | ||
| Pubmed | 9.22e-10 | 6 | 99 | 4 | 17876790 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 9.22e-10 | 6 | 99 | 4 | 8563024 | |
| Pubmed | 1.02e-09 | 17 | 99 | 5 | 29911975 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 1.40e-09 | 18 | 99 | 5 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 1.40e-09 | 18 | 99 | 5 | 10662547 | |
| Pubmed | 1.40e-09 | 18 | 99 | 5 | 9160753 | ||
| Pubmed | 1.62e-09 | 40 | 99 | 6 | 27068110 | ||
| Pubmed | 2.15e-09 | 7 | 99 | 4 | 17418794 | ||
| Pubmed | 3.31e-09 | 21 | 99 | 5 | 27856617 | ||
| Pubmed | 3.31e-09 | 21 | 99 | 5 | 23325811 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 4.29e-09 | 8 | 99 | 4 | 33875569 | |
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 9164858 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 18816857 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 15872058 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 1383086 | ||
| Pubmed | 4.29e-09 | 8 | 99 | 4 | 11683410 | ||
| Pubmed | 6.87e-09 | 24 | 99 | 5 | 24698270 | ||
| Pubmed | 7.70e-09 | 9 | 99 | 4 | 8995276 | ||
| Pubmed | 7.70e-09 | 9 | 99 | 4 | 10880400 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 2.24e-08 | 3 | 99 | 3 | 27576055 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 3025878 | ||
| Interaction | COLGALT2 interactions | COL4A1 COL4A2 COL4A5 COL8A1 COL9A2 COL9A3 COL13A1 FCN1 SCARA5 C1QTNF7 | 1.01e-12 | 67 | 99 | 10 | int:COLGALT2 |
| Interaction | DCN interactions | 3.20e-11 | 43 | 99 | 8 | int:DCN | |
| Interaction | LAIR2 interactions | 9.71e-11 | 49 | 99 | 8 | int:LAIR2 | |
| Interaction | HABP2 interactions | 2.13e-10 | 18 | 99 | 6 | int:HABP2 | |
| Interaction | OSM interactions | 4.42e-10 | 20 | 99 | 6 | int:OSM | |
| Interaction | FBLN2 interactions | 1.16e-09 | 66 | 99 | 8 | int:FBLN2 | |
| Interaction | MMP9 interactions | 1.31e-09 | 67 | 99 | 8 | int:MMP9 | |
| Interaction | CD93 interactions | 2.17e-09 | 45 | 99 | 7 | int:CD93 | |
| Interaction | MAG interactions | 5.23e-09 | 29 | 99 | 6 | int:MAG | |
| Interaction | SERPINE2 interactions | 1.06e-08 | 56 | 99 | 7 | int:SERPINE2 | |
| Interaction | PCDHA10 interactions | 6.37e-08 | 22 | 99 | 5 | int:PCDHA10 | |
| Interaction | TGFBI interactions | 1.27e-07 | 25 | 99 | 5 | int:TGFBI | |
| Interaction | MMP2 interactions | 2.36e-07 | 87 | 99 | 7 | int:MMP2 | |
| Interaction | PLOD3 interactions | COL4A1 COL4A2 COL4A6 COL9A2 COL9A3 COL13A1 COL17A1 COL23A1 AHNAK | 2.96e-07 | 183 | 99 | 9 | int:PLOD3 |
| Interaction | BGN interactions | 3.34e-07 | 30 | 99 | 5 | int:BGN | |
| Interaction | COL2A1 interactions | 7.18e-07 | 64 | 99 | 6 | int:COL2A1 | |
| Interaction | COL5A1 interactions | 7.88e-07 | 65 | 99 | 6 | int:COL5A1 | |
| Interaction | PLOD1 interactions | COL4A1 COL4A2 COL4A4 COL4A5 COL4A6 COL5A1 COL9A3 COL13A1 COL23A1 AHNAK | 1.75e-06 | 292 | 99 | 10 | int:PLOD1 |
| Interaction | COL4A2 interactions | 1.85e-06 | 75 | 99 | 6 | int:COL4A2 | |
| Interaction | COL8A2 interactions | 1.90e-06 | 42 | 99 | 5 | int:COL8A2 | |
| Interaction | COL5A2 interactions | 1.18e-05 | 29 | 99 | 4 | int:COL5A2 | |
| Interaction | ANTXR2 interactions | 1.18e-05 | 29 | 99 | 4 | int:ANTXR2 | |
| Interaction | COL5A3 interactions | 1.35e-05 | 10 | 99 | 3 | int:COL5A3 | |
| Interaction | MATN2 interactions | 1.99e-05 | 113 | 99 | 6 | int:MATN2 | |
| Interaction | PCDHA7 interactions | 4.02e-05 | 14 | 99 | 3 | int:PCDHA7 | |
| Interaction | COL1A2 interactions | 4.11e-05 | 78 | 99 | 5 | int:COL1A2 | |
| Interaction | C1QTNF1 interactions | 8.31e-05 | 47 | 99 | 4 | int:C1QTNF1 | |
| Interaction | COL4A1 interactions | 9.03e-05 | 48 | 99 | 4 | int:COL4A1 | |
| Interaction | NID1 interactions | 9.03e-05 | 48 | 99 | 4 | int:NID1 | |
| Interaction | PCDHA11 interactions | 1.05e-04 | 19 | 99 | 3 | int:PCDHA11 | |
| Interaction | PCDHA5 interactions | 1.42e-04 | 4 | 99 | 2 | int:PCDHA5 | |
| Interaction | SAA1 interactions | 1.44e-04 | 54 | 99 | 4 | int:SAA1 | |
| Interaction | CYSRT1 interactions | COL8A1 VASN ZBTB4 BRME1 ZNF34 CHRD ZFHX2 MAPKBP1 TRAPPC14 FAM83A | 2.08e-04 | 511 | 99 | 10 | int:CYSRT1 |
| Interaction | PCDHA4 interactions | 2.16e-04 | 60 | 99 | 4 | int:PCDHA4 | |
| Interaction | SPARC interactions | 2.95e-04 | 65 | 99 | 4 | int:SPARC | |
| Interaction | RUNX1T1 interactions | 4.09e-04 | 127 | 99 | 5 | int:RUNX1T1 | |
| Interaction | MLYCD interactions | 4.24e-04 | 30 | 99 | 3 | int:MLYCD | |
| Interaction | PDGFA interactions | 5.14e-04 | 32 | 99 | 3 | int:PDGFA | |
| Cytoband | 5q31 | 5.36e-06 | 115 | 99 | 5 | 5q31 | |
| Cytoband | 13q34 | 2.23e-04 | 54 | 99 | 3 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 4.84e-04 | 298 | 99 | 5 | chr5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 9.35e-04 | 88 | 99 | 3 | chr13q34 | |
| Cytoband | Xq22 | 1.03e-03 | 22 | 99 | 2 | Xq22 | |
| Cytoband | 3p21.31 | 1.35e-03 | 100 | 99 | 3 | 3p21.31 | |
| Cytoband | 7q36 | 1.56e-03 | 27 | 99 | 2 | 7q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 4.03e-03 | 147 | 99 | 3 | chr15q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 4.97e-03 | 316 | 99 | 4 | chr3p21 | |
| GeneFamily | Collagens | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 2.98e-45 | 46 | 69 | 23 | 490 |
| GeneFamily | Collagens|Collagen proteoglycans | 5.29e-07 | 5 | 69 | 3 | 575 | |
| GeneFamily | Clustered protocadherins | 4.47e-06 | 64 | 69 | 5 | 20 | |
| GeneFamily | Aldehyde dehydrogenases | 2.35e-03 | 19 | 69 | 2 | 398 | |
| GeneFamily | PDZ domain containing | 2.72e-03 | 152 | 69 | 4 | 1220 | |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 1.08e-45 | 43 | 99 | 23 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 COL1A2 | 2.25e-45 | 44 | 99 | 23 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 2.21e-26 | 270 | 99 | 24 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A1 COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 ELN COL1A2 | 3.45e-26 | 275 | 99 | 24 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A1 SEMA6C COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 FCN1 CHRD ELN C1QTNF7 COL1A2 | 4.39e-17 | 1008 | 99 | 28 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A1 SEMA6C COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL5A2 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL28A1 COL5A3 COL22A1 COL23A1 FCN1 CHRD ELN C1QTNF7 COL1A2 | 6.92e-17 | 1026 | 99 | 28 | M5889 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.06e-12 | 23 | 99 | 7 | M48001 | |
| Coexpression | GU_PDEF_TARGETS_UP | 2.72e-10 | 71 | 99 | 8 | M3955 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL11A1 ANK2 LMCD1 COL28A1 VASN COL5A3 TACC2 SHC2 KCNH1 CHRD ALDH1A3 COL1A2 | 4.17e-09 | 767 | 99 | 17 | M39209 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 8.62e-09 | 40 | 99 | 6 | M5887 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.29e-08 | 74 | 99 | 7 | M13547 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 5.52e-08 | 91 | 99 | 7 | M40180 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL13A1 COL5A3 HOXB2 SHC2 SCARA5 ALDH1A3 COL1A2 | 5.92e-08 | 505 | 99 | 13 | M39167 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL11A1 COL5A3 ELN COL1A2 | 7.01e-08 | 200 | 99 | 9 | M5930 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 5.63e-07 | 18 | 99 | 4 | M47984 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 ITPRIPL2 MAP1A LMCD1 VASN COL5A3 HOXB2 AHNAK COL1A2 | 1.75e-06 | 681 | 99 | 13 | M39175 |
| Coexpression | LIU_PROSTATE_CANCER_DN | COL4A1 COL4A2 COL4A6 COL5A1 COL7A1 COL9A1 COL13A1 ANK2 ALDH2 AHNAK2 COL1A2 | 2.65e-06 | 493 | 99 | 11 | M19391 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 4.23e-06 | 29 | 99 | 4 | MM17055 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 5.99e-06 | 68 | 99 | 5 | M45669 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 6.43e-06 | 120 | 99 | 6 | M42505 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.44e-06 | 69 | 99 | 5 | M10165 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 8.44e-06 | 11 | 99 | 3 | M47997 | |
| Coexpression | GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN | 1.12e-05 | 200 | 99 | 7 | M9067 | |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 1.12e-05 | 12 | 99 | 3 | MM3646 | |
| Coexpression | MANALO_HYPOXIA_UP | 1.31e-05 | 205 | 99 | 7 | M259 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.37e-05 | 137 | 99 | 6 | M40313 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.62e-05 | 141 | 99 | 6 | M10381 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.97e-05 | 146 | 99 | 6 | MM973 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 2.31e-05 | 44 | 99 | 4 | M18274 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 2.48e-05 | 152 | 99 | 6 | M16842 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 2.52e-05 | 313 | 99 | 8 | M40228 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL | 2.98e-05 | 233 | 99 | 7 | M45712 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 3.01e-05 | 47 | 99 | 4 | M7585 | |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN | 3.15e-05 | 235 | 99 | 7 | M2256 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN | 3.30e-05 | 160 | 99 | 6 | MM974 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.42e-05 | 17 | 99 | 3 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.42e-05 | 17 | 99 | 3 | M2223 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 3.75e-05 | 99 | 99 | 5 | M39152 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 3.86e-05 | 50 | 99 | 4 | MM403 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.09e-05 | 18 | 99 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.09e-05 | 18 | 99 | 3 | M13796 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 4.85e-05 | 19 | 99 | 3 | M15125 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.79e-05 | 352 | 99 | 8 | M17471 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 6.48e-05 | 111 | 99 | 5 | M1348 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 6.48e-05 | 111 | 99 | 5 | M45685 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 6.95e-05 | 58 | 99 | 4 | M178 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 7.22e-05 | 268 | 99 | 7 | M45796 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 8.32e-05 | 117 | 99 | 5 | M45663 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL9A2 COL17A1 PRX COL23A1 | 8.53e-05 | 479 | 99 | 9 | M2573 |
| Coexpression | DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS | 8.67e-05 | 118 | 99 | 5 | M40281 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL9A2 COL17A1 PRX COL23A1 | 9.08e-05 | 483 | 99 | 9 | MM1082 |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 9.10e-05 | 192 | 99 | 6 | M42501 | |
| Coexpression | PRC2_EZH2_UP.V1_UP | 9.10e-05 | 192 | 99 | 6 | M2739 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.02e-04 | 64 | 99 | 4 | M2572 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.08e-04 | 385 | 99 | 8 | M39264 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.09e-04 | 65 | 99 | 4 | M39309 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 1.13e-04 | 25 | 99 | 3 | M47986 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.27e-04 | 128 | 99 | 5 | MM1000 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.43e-04 | 27 | 99 | 3 | M47994 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL | 1.58e-04 | 304 | 99 | 7 | M45711 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | COL4A1 COL4A5 COL5A1 COL9A1 COL11A2 COL19A1 LMCD1 COL28A1 BRME1 COL5A3 COL22A1 GALNT7 SLC10A7 | 1.68e-04 | 1054 | 99 | 13 | M45798 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 1.82e-04 | 218 | 99 | 6 | M1099 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | COL4A6 ITPRIPL2 LMCD1 ZBTB4 COL5A3 TACC2 STAMBP SSH3 AHNAK MAPKBP1 AHNAK2 | 1.82e-04 | 783 | 99 | 11 | M2488 |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 1.97e-04 | 30 | 99 | 3 | M1550 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 1.99e-04 | 76 | 99 | 4 | M11825 | |
| Coexpression | HAY_BONE_MARROW_FOLLICULAR_B_CELL | 2.07e-04 | 142 | 99 | 5 | M39198 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.10e-04 | 6 | 99 | 2 | M48000 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 2.18e-04 | 31 | 99 | 3 | MM665 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.55e-04 | 81 | 99 | 4 | M39253 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 2.58e-04 | 149 | 99 | 5 | M45703 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.63e-04 | 33 | 99 | 3 | M9167 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 2.73e-04 | 235 | 99 | 6 | MM978 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 2.80e-04 | 83 | 99 | 4 | M2448 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRN | 2.85e-04 | 335 | 99 | 7 | M39065 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | COL4A5 COL4A6 COL8A1 COL9A2 FRMPD4 MNX1 MAP6 POLR3GL CNNM1 HOXB2 KCNH1 CHRD NXPH4 | 2.89e-04 | 1115 | 99 | 13 | M10371 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 2.92e-04 | 238 | 99 | 6 | M2020 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 2.95e-04 | 337 | 99 | 7 | MM16606 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.13e-04 | 35 | 99 | 3 | M11788 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 3.26e-04 | 243 | 99 | 6 | M14072 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.41e-04 | 36 | 99 | 3 | MM1212 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 3.50e-04 | 88 | 99 | 4 | M5360 | |
| Coexpression | LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES | 3.70e-04 | 37 | 99 | 3 | M1726 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 3.86e-04 | 465 | 99 | 8 | M39066 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 3.91e-04 | 163 | 99 | 5 | M2769 | |
| Coexpression | LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES | 4.33e-04 | 39 | 99 | 3 | MM722 | |
| Coexpression | JAEGER_METASTASIS_DN | 4.66e-04 | 260 | 99 | 6 | M10702 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_3_DN | 4.67e-04 | 40 | 99 | 3 | M2169 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN | 4.73e-04 | 170 | 99 | 5 | M5649 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | 4.76e-04 | 261 | 99 | 6 | MM1277 | |
| Coexpression | HASEGAWA_TUMORIGENESIS_BY_RET_C634R | 5.00e-04 | 9 | 99 | 2 | M1334 | |
| Coexpression | VALK_AML_WITH_FLT3_ITD | 5.02e-04 | 41 | 99 | 3 | M10010 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL | 5.07e-04 | 97 | 99 | 4 | M45794 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | 5.15e-04 | 611 | 99 | 9 | M1106 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL | 5.39e-04 | 42 | 99 | 3 | M45688 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 5.83e-04 | 178 | 99 | 5 | M17079 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 6.05e-04 | 380 | 99 | 7 | M45714 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN | 6.29e-04 | 181 | 99 | 5 | M8889 | |
| Coexpression | BENPORATH_EED_TARGETS | COL4A5 COL4A6 COL9A2 RIN3 FRMPD4 COL19A1 MNX1 CNNM1 HOXB2 KCNH1 CHRD NXPH4 | 6.47e-04 | 1059 | 99 | 12 | M7617 |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN | 6.61e-04 | 45 | 99 | 3 | M13714 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_A | 6.83e-04 | 105 | 99 | 4 | M14228 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SEMA6C COL4A4 COL4A5 COL4A6 COL5A1 COL8A1 COL9A2 COL11A1 COL13A1 ZBTB4 COL23A1 TRPM5 SYNE2 ROBO2 ELN C1QTNF7 ALDH1A3 AHNAK2 COL1A2 | 3.65e-09 | 790 | 99 | 19 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | SEMA6C COL4A5 COL4A6 COL5A1 COL11A1 ZBTB4 TRPM5 ALDH1A3 AHNAK2 COL1A2 | 2.86e-08 | 197 | 99 | 10 | gudmap_developingGonad_e16.5_epididymis_1000_k5 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 COL9A2 COL11A1 MAP1A MAP6 LMCD1 COL5A3 HOXB2 SHC2 FMN2 ROBO2 ELN C1QTNF7 COL1A2 | 2.72e-06 | 1094 | 99 | 18 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | MAFG SEMA6C COL4A4 COL4A5 COL4A6 COL5A1 COL8A1 COL11A1 COL23A1 TRPM5 SYNE2 ELN C1QTNF7 AHNAK2 COL1A2 | 4.27e-06 | 799 | 99 | 15 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A1 SEMA6C COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL9A2 COL9A3 COL11A1 COL13A1 POLR3GL VASN ZBTB4 COL23A1 SHC2 AHNAK FMN2 | 5.65e-06 | 1153 | 99 | 18 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | COL5A2 COL7A1 COL13A1 VASN PCDHA12 PCDHA10 PCDHA5 COL22A1 COL1A2 | 6.70e-06 | 281 | 99 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | COL5A2 COL7A1 COL13A1 VASN PCDHA12 PCDHA10 PCDHA5 COL22A1 COL1A2 | 6.70e-06 | 281 | 99 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | SEMA6C COL7A1 COL8A1 COL9A2 ITPRIPL2 COL17A1 POLR3GL LMCD1 CECR2 ZBTB4 TRPM5 FMN2 ELN C1QTNF7 ALDH1A3 COL1A2 | 9.79e-06 | 967 | 99 | 16 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | SEMA6C COL4A2 COL4A5 COL4A6 COL5A2 COL7A1 COL9A2 COL11A1 ANK2 POLR3GL VASN ZBTB4 IRF7 COL22A1 RXRB SH2B1 SHC2 AHNAK ALDH2 COL1A2 | 1.18e-05 | 1466 | 99 | 20 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.84e-05 | 319 | 99 | 9 | gudmap_developingGonad_P2_testes_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SEMA6C COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL11A1 COL23A1 TRPM5 SYNE2 ELN C1QTNF7 AHNAK2 COL1A2 | 1.94e-05 | 797 | 99 | 14 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.41e-05 | 123 | 99 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | BM Top 100 - trigeminal ganglia | 2.65e-05 | 75 | 99 | 5 | BM Top 100 - trigeminal ganglia | |
| CoexpressionAtlas | cerebral cortex | COL9A3 FRMPD4 ANK2 MAP1A MAP6 CECR2 PCDHA10 PCDHA5 GPRIN1 ARFGEF3 CNNM1 RTP5 KCNH1 CASKIN1 FMN2 ROBO2 BSN PNMA6A NXPH4 | 2.87e-05 | 1428 | 99 | 19 | cerebral cortex |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | SEMA6C COL5A1 COL5A2 COL7A1 RIN3 COL9A3 COL11A1 SZT2 FYCO1 COL23A1 TRPM5 FAM193A USP42 ROBO2 ELN C1QTNF7 COL1A2 | 4.02e-05 | 1208 | 99 | 17 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | SEMA6C COL7A1 COL8A1 COL9A2 ITPRIPL2 COL17A1 MAP1A POLR3GL LMCD1 ZBTB4 TRPM5 FMN2 ELN C1QTNF7 COL1A2 | 4.04e-05 | 967 | 99 | 15 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | COL7A1 COL8A1 COL9A1 COL9A2 ITPRIPL2 POLR3GL LMCD1 CECR2 ZBTB4 TRPM5 FMN2 ELN C1QTNF7 ALDH1A3 COL1A2 | 4.04e-05 | 967 | 99 | 15 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | COL4A4 COL8A1 COL13A1 MAP1A VASN COL5A3 IHO1 MOV10L1 FMN2 ELN C1QTNF7 ALDH1A3 NXPH4 AHNAK2 COL1A2 | 4.44e-05 | 975 | 99 | 15 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL8A1 COL9A2 COL13A1 MNX1 CNNM1 SHC2 KCNH1 AHNAK FMN2 | 4.81e-05 | 982 | 99 | 15 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | COL5A1 COL7A1 COL8A1 COL11A1 LMCD1 VASN COL5A3 CNNM1 KCNH1 SCARA5 MOV10L1 FMN2 ELN NXPH4 COL1A2 | 5.28e-05 | 990 | 99 | 15 | JC_fibro_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.50e-05 | 214 | 99 | 7 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | COL4A5 COL4A6 COL5A1 COL5A2 COL9A2 COL13A1 MNX1 SHC2 KCNH1 FMN2 | 8.20e-05 | 480 | 99 | 10 | ratio_MESO_vs_SC_1000_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | COL8A1 COL9A1 ITPRIPL2 LMCD1 CECR2 TRPM5 FMN2 ELN C1QTNF7 ALDH1A3 | 8.63e-05 | 483 | 99 | 10 | Facebase_RNAseq_e9.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | COL7A1 COL8A1 ITPRIPL2 LMCD1 CECR2 TRPM5 FMN2 ELN C1QTNF7 COL1A2 | 9.55e-05 | 489 | 99 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.01e-04 | 159 | 99 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | COL4A4 COL4A5 COL11A1 COL23A1 TRPM5 SYNE2 ELN C1QTNF7 COL1A2 | 1.14e-04 | 404 | 99 | 9 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | COL4A5 COL11A1 COL13A1 COL23A1 TRPM5 SYNE2 ROBO2 C1QTNF7 COL1A2 | 1.35e-04 | 413 | 99 | 9 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | COL7A1 COL8A1 COL9A2 ITPRIPL2 POLR3GL LMCD1 ZBTB4 TRPM5 FMN2 ELN C1QTNF7 ALDH1A3 CARS2 COL1A2 | 1.63e-04 | 972 | 99 | 14 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL4A6 COL5A1 COL5A2 COL8A1 COL9A2 RIN3 COL13A1 ITPRIPL2 MNX1 COL22A1 SHC2 AHNAK FMN2 ALDH1A3 | 1.70e-04 | 976 | 99 | 14 | PCBC_ratio_DE_vs_SC_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.77e-04 | 336 | 99 | 8 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | COL7A1 COL8A1 ITPRIPL2 LMCD1 CECR2 GALNT7 TRPM5 SYNE2 ZFHX2 FMN2 ELN C1QTNF7 ALDH1A3 COL1A2 | 1.85e-04 | 984 | 99 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 2.28e-04 | 64 | 99 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | COL5A2 COL9A2 COL9A3 ITPRIPL2 COL17A1 PYROXD1 VASN FYCO1 ALDH2 CARS2 COL1A2 | 2.29e-04 | 652 | 99 | 11 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | SEMA6C COL4A5 COL7A1 COL8A1 COL11A1 ITPRIPL2 ANK2 MAP1A MAPKBP1 | 2.43e-04 | 447 | 99 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 3.59e-04 | 72 | 99 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | COL4A1 COL4A4 COL5A1 RIN3 GALNT7 COL23A1 KCNH1 SCARA5 SYNE2 MOV10L1 ELN C1QTNF7 | 4.03e-04 | 814 | 99 | 12 | gudmap_developingGonad_e18.5_testes_1000 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | COL5A1 COL5A2 COL8A1 COL11A1 MAP6 LMCD1 VASN COL5A3 KCNH1 FMN2 ELN COL1A2 | 4.03e-04 | 814 | 99 | 12 | JC_fibro_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.21e-04 | 207 | 99 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.47e-04 | 293 | 99 | 7 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 4.48e-04 | 486 | 99 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | 4.56e-04 | 294 | 99 | 7 | ratio_MESO_vs_SC_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 4.61e-04 | 488 | 99 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 4.87e-04 | 78 | 99 | 4 | PCBC_ratio_DE_from-OSKM_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.88e-04 | 139 | 99 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 5.04e-04 | 494 | 99 | 9 | JC_fibro_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_500 | 5.11e-04 | 495 | 99 | 9 | PCBC_ratio_MESO-5_vs_SC_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.21e-04 | 141 | 99 | 5 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | COL7A1 COL8A1 COL9A2 ITPRIPL2 POLR3GL LMCD1 CECR2 ZBTB4 TRPM5 FMN2 ELN C1QTNF7 COL1A2 | 5.54e-04 | 968 | 99 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | COL5A2 COL9A2 COL9A3 COL17A1 POLR3GL PYROXD1 TRPM5 ELN C1QTNF7 ALDH2 COL1A2 | 5.67e-04 | 726 | 99 | 11 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_200 | 5.77e-04 | 35 | 99 | 3 | gudmap_developingKidney_e15.5_Podocyte cells_200_k2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_top-relative-expression-ranked_1000 | COL4A6 COL9A1 COL9A2 COL9A3 MNX1 CECR2 PCDHA12 PCDHA10 PCDHA2 COL23A1 ARFGEF3 PLEKHG6 FMN2 | 5.87e-04 | 974 | 99 | 13 | PCBC_MESO-5_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | COL7A1 COL8A1 ITPRIPL2 MAP1A LMCD1 CECR2 ZBTB4 TRPM5 ZFHX2 FMN2 ELN C1QTNF7 COL1A2 | 5.98e-04 | 976 | 99 | 13 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | COL5A2 COL9A2 COL9A3 ITPRIPL2 COL17A1 PYROXD1 VASN FYCO1 ELN ALDH2 COL1A2 | 6.01e-04 | 731 | 99 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | COL7A1 COL8A1 COL9A1 ITPRIPL2 LMCD1 CECR2 ZBTB4 TRPM5 MOV10L1 FMN2 ELN C1QTNF7 COL1A2 | 6.10e-04 | 978 | 99 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 6.27e-04 | 406 | 99 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | COL4A5 COL8A1 ANK2 MAP1A LMCD1 CECR2 TRPM5 SYNE2 MOV10L1 FMN2 ELN C1QTNF7 TRAPPC14 | 6.40e-04 | 983 | 99 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL5A1 COL9A1 COL11A1 COL11A2 MAP6 LMCD1 CECR2 HOXB2 SHC2 ROBO2 BSN NXPH4 COL1A2 | 6.58e-04 | 986 | 99 | 13 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.74e-04 | 85 | 99 | 4 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | MESO-5 blastocyst_vs_MESO-5 bone marrow-Confounder_removed-fold2.0_adjp0.05 | 7.04e-04 | 86 | 99 | 4 | PCBC_ratio_MESO-5 blastocyst_vs_MESO-5 bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.39e-04 | 319 | 99 | 7 | ratio_DE_vs_SC_1000_K3 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 7.53e-04 | 320 | 99 | 7 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_500 | 7.95e-04 | 39 | 99 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.02e-04 | 234 | 99 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.72e-04 | 158 | 99 | 5 | gudmap_developingGonad_e12.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 9.07e-04 | 92 | 99 | 4 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | COL4A4 COL9A1 ZBTB4 COL5A3 FCN1 SCARA5 AHNAK ELN ALDH2 ALDH1A3 AHNAK2 | 9.59e-04 | 774 | 99 | 11 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_500 | 9.83e-04 | 94 | 99 | 4 | gudmap_developingGonad_e18.5_testes_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | COL5A1 COL5A2 COL7A1 COL11A1 ANK2 FYCO1 COL23A1 ARFGEF3 TRPM5 FAM193A ROBO2 ELN C1QTNF7 COL1A2 | 1.01e-03 | 1166 | 99 | 14 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | COL4A4 COL8A1 ZBTB4 COL5A3 FCN1 SCARA5 AHNAK ELN ALDH2 AHNAK2 COL1A2 | 1.05e-03 | 783 | 99 | 11 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 1.09e-03 | 166 | 99 | 5 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.13e-03 | 445 | 99 | 8 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | MAFG SEMA6C COL4A5 COL11A1 COL13A1 COL23A1 TRPM5 SYNE2 ROBO2 C1QTNF7 COL1A2 | 1.26e-03 | 801 | 99 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.27e-03 | 256 | 99 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 1.38e-03 | 175 | 99 | 5 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A5 COL7A1 COL9A1 COL11A1 VASN ZBTB4 TACC2 COL22A1 RXRB SH2B1 SHC2 ALDH2 COL1A2 | 1.45e-03 | 1075 | 99 | 13 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.48e-03 | 464 | 99 | 8 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | COL4A4 COL5A1 RIN3 COL9A3 GALNT7 COL23A1 KCNH1 SYNE2 MOV10L1 ELN C1QTNF7 | 1.51e-03 | 819 | 99 | 11 | gudmap_developingGonad_e16.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | COL4A3 COL4A4 COL5A1 RIN3 GALNT7 COL23A1 SCARA5 SYNE2 MOV10L1 ELN C1QTNF7 | 1.51e-03 | 819 | 99 | 11 | gudmap_developingGonad_P2_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.52e-03 | 265 | 99 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | SEMA6C COL5A1 COL5A2 COL9A3 COL11A1 R3HCC1 GGCX COL23A1 TRPM5 NYNRIN ROBO2 ELN ALDH2 TRAPPC14 | 1.65e-03 | 1228 | 99 | 14 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.73e-03 | 589 | 99 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 1.80e-03 | 479 | 99 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL4A6 COL9A1 COL9A2 COL9A3 MNX1 CECR2 PCDHA12 COL23A1 CNNM1 SHC2 KCNH1 FMN2 | 1.82e-03 | 969 | 99 | 12 | PCBC_MESO-5_fibroblast_1000 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 ANK2 MAP1A LMCD1 VASN COL5A3 ELN ALDH1A3 COL1A2 | 7.90e-16 | 200 | 99 | 13 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 ANK2 MAP1A LMCD1 VASN COL5A3 ELN ALDH1A3 COL1A2 | 7.90e-16 | 200 | 99 | 13 | 444c72334df421375ae6fc69b0adfd4950d49a43 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 ANK2 MAP1A LMCD1 VASN COL5A3 ELN ALDH1A3 COL1A2 | 7.90e-16 | 200 | 99 | 13 | 5826c17da67bdaba3a828792279004218d8260c8 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL5A1 COL5A2 COL7A1 COL8A1 ANK2 VASN SCARA5 ROBO2 ELN C1QTNF7 ALDH1A3 COL1A2 | 2.81e-14 | 200 | 99 | 12 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL8A1 COL5A3 SCARA5 CHRD ELN COL1A2 | 2.87e-13 | 180 | 99 | 11 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL4A4 COL5A1 COL5A2 COL8A1 COL5A3 SCARA5 ELN COL1A2 | 5.82e-13 | 192 | 99 | 11 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL4A4 COL5A1 COL5A2 COL8A1 COL5A3 SCARA5 ELN COL1A2 | 6.16e-13 | 193 | 99 | 11 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL8A1 COL11A1 COL13A1 COL5A3 AHNAK COL1A2 | 6.90e-13 | 195 | 99 | 11 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL8A1 COL13A1 ANK2 LMCD1 VASN ROBO2 ELN C1QTNF7 COL1A2 | 7.71e-13 | 197 | 99 | 11 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL5A1 COL5A2 COL8A1 COL13A1 ANK2 VASN ROBO2 ELN C1QTNF7 ALDH1A3 COL1A2 | 8.15e-13 | 198 | 99 | 11 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COL5A2 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 VASN ELN COL1A2 | 8.15e-13 | 198 | 99 | 11 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL5A1 COL5A2 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 VASN ELN COL1A2 | 8.15e-13 | 198 | 99 | 11 | 1beed34f469aad07e8f674f0b668d6e1e916403c |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL11A1 COL11A2 VASN COL5A3 ELN COL1A2 | 8.15e-13 | 198 | 99 | 11 | b086af292a508a156266c2d899ba1caf820bf61c |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL5A1 COL5A2 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 VASN ELN COL1A2 | 8.15e-13 | 198 | 99 | 11 | 985022c1722ab7b67675ebe814022a439e715b5e |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 ANK2 VASN SCARA5 CHRD ELN COL1A2 | 9.10e-13 | 200 | 99 | 11 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL4A1 COL4A2 COL5A1 COL5A2 ANK2 LMCD1 VASN COL5A3 SCARA5 ELN COL1A2 | 9.10e-13 | 200 | 99 | 11 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 ANK2 VASN SCARA5 CHRD ELN COL1A2 | 9.10e-13 | 200 | 99 | 11 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 COL9A1 COL11A1 COL11A2 ANK2 SCARA5 COL1A2 | 9.10e-13 | 200 | 99 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL4A1 COL4A2 COL5A1 COL5A2 LMCD1 CNNM1 ROBO2 ELN C1QTNF7 COL1A2 | 9.35e-12 | 180 | 99 | 10 | 01f2e5d96016823482f89ba503d007d4bd88eeac |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL4A1 COL4A2 COL5A1 COL7A1 LMCD1 TACC2 COL22A1 COL23A1 ROBO2 C1QTNF7 | 1.04e-11 | 182 | 99 | 10 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL4A4 COL5A1 COL5A2 COL8A1 COL5A3 SCARA5 ELN | 1.60e-11 | 190 | 99 | 10 | 12992ec80a7b4f4f17de693f0719ee061a9918fd |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL8A1 ANK2 VASN COL5A3 SCARA5 ELN C1QTNF7 COL1A2 | 1.68e-11 | 191 | 99 | 10 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A3 COL4A4 COL5A1 COL5A2 COL8A1 COL5A3 SCARA5 CHRD C1QTNF7 COL1A2 | 1.77e-11 | 192 | 99 | 10 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL8A1 ANK2 VASN SCARA5 ROBO2 ELN C1QTNF7 COL1A2 | 1.77e-11 | 192 | 99 | 10 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A3 COL4A4 COL5A1 COL5A2 COL8A1 COL5A3 SCARA5 CHRD C1QTNF7 COL1A2 | 1.77e-11 | 192 | 99 | 10 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | COL4A1 COL4A2 COL4A3 COL4A4 COL5A1 COL5A2 COL8A1 SCARA5 ELN COL1A2 | 1.97e-11 | 194 | 99 | 10 | 11c79a8c56ece42713b04b321982e41e239f07a5 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A5 COL5A1 COL5A2 COL5A3 COL23A1 SCARA5 ELN C1QTNF7 COL1A2 | 1.97e-11 | 194 | 99 | 10 | 3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1 |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A1 COL4A5 COL5A1 COL5A2 COL5A3 COL23A1 SCARA5 ELN C1QTNF7 COL1A2 | 1.97e-11 | 194 | 99 | 10 | ff19fb5bc7feae3e774ef4ab720beb9dec219f45 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL9A2 LMCD1 HOXB2 SCARA5 CHRD ROBO2 ELN C1QTNF7 ALDH2 COL1A2 | 2.07e-11 | 195 | 99 | 10 | a486a7acea0e91048cc48afa0dbd3926d30bc217 |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL9A2 LMCD1 HOXB2 SCARA5 CHRD ROBO2 ELN C1QTNF7 ALDH2 COL1A2 | 2.07e-11 | 195 | 99 | 10 | 2414b158dc7bdec43a9671544bfb7ffc5f5168fd |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL8A1 COL13A1 LMCD1 VASN ROBO2 ELN C1QTNF7 COL1A2 | 2.17e-11 | 196 | 99 | 10 | 9737a5f006d37b549f281e1863aca558e1e4dc99 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL8A1 COL13A1 LMCD1 VASN ROBO2 ELN C1QTNF7 COL1A2 | 2.17e-11 | 196 | 99 | 10 | cecf82cd5e0a3835d655f5e7478578674a63ce25 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL8A1 COL11A1 VASN COL5A3 COL1A2 | 2.40e-11 | 198 | 99 | 10 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A5 COL5A1 COL5A2 VASN COL5A3 SCARA5 ELN C1QTNF7 COL1A2 | 2.40e-11 | 198 | 99 | 10 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL4A1 COL4A2 COL5A1 COL5A2 COL7A1 COL8A1 COL11A1 VASN COL5A3 COL1A2 | 2.40e-11 | 198 | 99 | 10 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 VASN SCARA5 ROBO2 ELN COL1A2 | 2.40e-11 | 198 | 99 | 10 | ece914c32c9b123b779aa9624b92e6230763a20e |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL9A1 COL11A1 COL11A2 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 2.53e-11 | 199 | 99 | 10 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL4A1 COL4A2 COL4A5 COL4A6 COL5A1 COL5A2 COL9A1 LMCD1 ALDH1A3 COL1A2 | 2.53e-11 | 199 | 99 | 10 | ec74ff85d6b61013b1f785b2fca343759feb7843 |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL5A1 COL5A2 COL8A1 COL13A1 VASN SCARA5 ROBO2 ELN C1QTNF7 COL1A2 | 2.53e-11 | 199 | 99 | 10 | e1f1950d6f840485e263b83dc81b98910be3ae7a |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 COL5A2 COL8A1 COL13A1 ANK2 SCARA5 ROBO2 ELN C1QTNF7 COL1A2 | 2.53e-11 | 199 | 99 | 10 | fb580e9321ddf97c73b2e356cd82523db74a38a2 |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL9A1 COL11A1 COL11A2 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 2.53e-11 | 199 | 99 | 10 | bf138cc692df727e087d140c014149ee5da00d9d |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | COL5A1 COL5A2 COL8A1 COL13A1 ANK2 VASN ROBO2 ELN C1QTNF7 COL1A2 | 2.66e-11 | 200 | 99 | 10 | e504570fd7eec1524c401b1cfa9d10822d80d994 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL4A1 COL4A2 COL5A1 COL5A2 ANK2 LMCD1 SCARA5 ROBO2 ELN COL1A2 | 2.66e-11 | 200 | 99 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COL5A1 COL5A2 COL8A1 COL13A1 ANK2 LMCD1 ROBO2 ELN C1QTNF7 COL1A2 | 2.66e-11 | 200 | 99 | 10 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | COL4A1 COL4A2 COL5A1 COL5A2 ANK2 VASN SCARA5 ELN ALDH1A3 COL1A2 | 2.66e-11 | 200 | 99 | 10 | 954fee8425673e76198be414f5f6c4e3597c1919 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | COL4A1 COL4A2 COL5A1 COL5A2 COL13A1 COL5A3 SCARA5 C1QTNF7 ALDH1A3 COL1A2 | 2.66e-11 | 200 | 99 | 10 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL4A1 COL4A2 COL5A1 COL5A2 COL8A1 ANK2 SCARA5 ELN C1QTNF7 COL1A2 | 2.66e-11 | 200 | 99 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | COL4A1 COL4A2 COL5A1 COL5A2 COL13A1 COL5A3 SCARA5 C1QTNF7 ALDH1A3 COL1A2 | 2.66e-11 | 200 | 99 | 10 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL8A1 COL11A1 COL11A2 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 2.66e-11 | 200 | 99 | 10 | 3c898e81444b001835c3f1bbc68183078701b135 |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL8A1 COL11A1 COL11A2 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 2.66e-11 | 200 | 99 | 10 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL5A1 COL5A2 COL9A3 COL13A1 COL5A3 ROBO2 C1QTNF7 ALDH1A3 COL1A2 | 8.06e-11 | 157 | 99 | 9 | f147e24f2ece82e1c54750868954d09b3c461804 |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | COL5A1 COL5A2 COL9A3 COL13A1 ROBO2 ELN C1QTNF7 ALDH1A3 COL1A2 | 8.53e-11 | 158 | 99 | 9 | e5636c0b608d68bd426a2b446ac508e4512e86a4 |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-10 | 166 | 99 | 9 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-10 | 173 | 99 | 9 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL4A3 COL5A1 COL5A2 COL11A1 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 2.47e-10 | 178 | 99 | 9 | e32f5ed7a492edfa7073416008b1fcfae6b854ad |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL11A2 COL13A1 FRMPD4 VASN COL22A1 ROBO2 COL1A2 | 3.01e-10 | 182 | 99 | 9 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 3.32e-10 | 184 | 99 | 9 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-10 | 186 | 99 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.83e-10 | 187 | 99 | 9 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | COL5A2 COL11A1 COL11A2 COL13A1 COL22A1 HOXB2 SHC2 ROBO2 COL1A2 | 4.01e-10 | 188 | 99 | 9 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.21e-10 | 189 | 99 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL4A1 COL4A2 COL5A2 COL19A1 COL5A3 SCARA5 ELN ALDH1A3 COL1A2 | 4.21e-10 | 189 | 99 | 9 | c392491aabe8a3e90974ab2ea123bbbe5200439d |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.41e-10 | 190 | 99 | 9 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-10 | 190 | 99 | 9 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-10 | 190 | 99 | 9 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A4 COL5A1 COL5A2 COL8A1 COL5A3 SCARA5 CHRD COL1A2 | 4.62e-10 | 191 | 99 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.62e-10 | 191 | 99 | 9 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.62e-10 | 191 | 99 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.83e-10 | 192 | 99 | 9 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.83e-10 | 192 | 99 | 9 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-10 | 192 | 99 | 9 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.83e-10 | 192 | 99 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Lung-30m-Mesenchymal|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-10 | 192 | 99 | 9 | 5d5bec238b196f0b3e727fd94f078d6ae524cb01 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL4A5 COL5A1 COL5A2 COL13A1 SCARA5 ROBO2 ELN C1QTNF7 COL1A2 | 5.06e-10 | 193 | 99 | 9 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-10 | 193 | 99 | 9 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | COL4A5 COL5A1 COL5A2 COL13A1 SCARA5 ROBO2 ELN C1QTNF7 COL1A2 | 5.06e-10 | 193 | 99 | 9 | 30481fb01c7acf85beae10213f038da86bed6777 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.30e-10 | 194 | 99 | 9 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 5.30e-10 | 194 | 99 | 9 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.30e-10 | 194 | 99 | 9 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.54e-10 | 195 | 99 | 9 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.54e-10 | 195 | 99 | 9 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.54e-10 | 195 | 99 | 9 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL4A1 COL4A2 COL4A5 COL5A1 COL5A2 COL11A1 COL11A2 ELN COL1A2 | 5.54e-10 | 195 | 99 | 9 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 5.54e-10 | 195 | 99 | 9 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 5.80e-10 | 196 | 99 | 9 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.80e-10 | 196 | 99 | 9 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.80e-10 | 196 | 99 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | COL4A1 COL4A2 COL4A4 COL5A1 COL5A2 COL7A1 COL5A3 C1QTNF7 COL1A2 | 5.80e-10 | 196 | 99 | 9 | 12d9028f90c057c6e5cff00301793fa550e86c5a |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL11A1 COL11A2 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 5.80e-10 | 196 | 99 | 9 | d5ed41fa111750e6b363c04cccc40a47dd774852 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL11A1 COL11A2 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 5.80e-10 | 196 | 99 | 9 | 760885dc608c82768fe0decd63ed9fda8315f453 |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.07e-10 | 197 | 99 | 9 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL9A1 COL11A1 COL13A1 VASN COL22A1 ROBO2 COL1A2 | 6.07e-10 | 197 | 99 | 9 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-10 | 197 | 99 | 9 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-10 | 197 | 99 | 9 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COL5A1 COL5A2 COL13A1 COL5A3 SCARA5 ROBO2 ELN C1QTNF7 COL1A2 | 6.07e-10 | 197 | 99 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 6.07e-10 | 197 | 99 | 9 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL9A1 COL11A1 COL11A2 COL13A1 COL22A1 ROBO2 COL1A2 | 6.34e-10 | 198 | 99 | 9 | 1f956e369e00d37835095a001db4b62a79014532 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | COL5A1 COL5A2 COL9A1 COL11A1 COL11A2 COL13A1 COL22A1 ROBO2 COL1A2 | 6.34e-10 | 198 | 99 | 9 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-10 | 198 | 99 | 9 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.34e-10 | 198 | 99 | 9 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| Computational | Adhesion molecules. | COL4A1 COL4A5 COL5A1 COL5A2 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 ELN | 3.98e-09 | 141 | 59 | 10 | MODULE_122 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.78e-07 | 50 | 59 | 6 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.56e-04 | 50 | 59 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Neighborhood of CDH11 | 3.32e-04 | 25 | 59 | 3 | GNF2_CDH11 | |
| Computational | Neighborhood of CDH3 | 4.18e-04 | 27 | 59 | 3 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 4.67e-04 | 28 | 59 | 3 | GNF2_SERPINB5 | |
| Computational | Neighborhood of PTX3 | 9.86e-04 | 36 | 59 | 3 | GNF2_PTX3 | |
| Drug | BAPN | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 ELN COL1A2 | 1.55e-29 | 71 | 99 | 19 | CID000001647 |
| Drug | GK-101 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 3.11e-29 | 36 | 99 | 16 | CID000161853 |
| Drug | 4-hydroxyproline | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 CHRD ELN COL1A2 | 3.88e-29 | 91 | 99 | 20 | CID000000825 |
| Drug | AC1LAKND | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 COL1A2 | 9.55e-29 | 62 | 99 | 18 | CID000470146 |
| Drug | Madecassol | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 4.08e-27 | 46 | 99 | 16 | CID000108062 |
| Drug | d-indobufen | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 2.00e-26 | 50 | 99 | 16 | CID000044562 |
| Drug | ridogrel | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 4.18e-26 | 52 | 99 | 16 | CID005362391 |
| Drug | halofuginone lactate | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 COL1A2 | 5.77e-26 | 85 | 99 | 18 | CID000062891 |
| Drug | NSC49633 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 5.96e-26 | 53 | 99 | 16 | CID000023340 |
| Drug | hydroxylysine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 ELN COL1A2 | 1.26e-25 | 109 | 99 | 19 | CID000001029 |
| Drug | ticlopidine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 COL1A2 | 2.47e-24 | 103 | 99 | 18 | CID000005472 |
| Drug | DMSe | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL5A3 COL22A1 COL23A1 HOXB2 ELN COL1A2 | 6.02e-24 | 132 | 99 | 19 | CID000020796 |
| Drug | malotilate | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 1.21e-23 | 71 | 99 | 16 | CID000004006 |
| Drug | DL-penicillamine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 ELN COL1A2 | 1.69e-23 | 139 | 99 | 19 | CID000004727 |
| Drug | Tranilast sodium | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 COL1A2 | 2.05e-23 | 115 | 99 | 18 | CID000005527 |
| Drug | AC1NMZ1B | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 3.18e-23 | 75 | 99 | 16 | CID005034185 |
| Drug | strontium ranelate | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 5.05e-23 | 77 | 99 | 16 | CID006918182 |
| Drug | pirfenidone | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 COL1A2 | 6.45e-22 | 138 | 99 | 18 | CID000040632 |
| Drug | PCR 4099 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 COL1A2 | 7.39e-22 | 139 | 99 | 18 | CID000002806 |
| Drug | candesartan cilexetil | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 MOV10L1 NOS3 COL1A2 | 1.63e-21 | 145 | 99 | 18 | CID000002540 |
| Drug | AC1L1DD6 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 ELN COL1A2 | 2.43e-21 | 179 | 99 | 19 | CID000002299 |
| Drug | Selara | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 NOS3 COL1A2 | 4.60e-21 | 125 | 99 | 17 | CID000150310 |
| Drug | AC1L1C2F | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 2.30e-20 | 110 | 99 | 16 | CID000001711 |
| Drug | khellin | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 COL1A2 | 3.45e-20 | 171 | 99 | 18 | CID000003828 |
| Drug | PPACK | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 3.62e-20 | 113 | 99 | 16 | CID003036757 |
| Drug | AC1L9732 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 4.20e-20 | 114 | 99 | 16 | CID000439300 |
| Drug | AC1Q6PCP | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 NOS3 COL1A2 | 3.00e-19 | 230 | 99 | 19 | CID000005267 |
| Drug | hyaluronan | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 ELN COL1A2 | 3.79e-18 | 263 | 99 | 19 | CID000024759 |
| Drug | foscarnet | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 BSN COL1A2 | 6.79e-18 | 190 | 99 | 17 | CID000003414 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 1.38e-17 | 162 | 99 | 16 | CID000072363 |
| Drug | silibinin | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 CNNM1 COL1A2 | 1.70e-17 | 285 | 99 | 19 | CID000005213 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 1.66e-16 | 189 | 99 | 16 | CID000001413 |
| Drug | AC1L18QD | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 NOS3 COL1A2 | 1.95e-16 | 325 | 99 | 19 | CID000000213 |
| Drug | losartan | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 MOV10L1 NOS3 COL1A2 | 1.99e-16 | 378 | 99 | 20 | CID000003961 |
| Drug | colchine | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 BSN NOS3 COL1A2 | 2.56e-16 | 383 | 99 | 20 | CID000002833 |
| Drug | prostacyclin sodium salt | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 NOS3 COL1A2 | 7.03e-16 | 250 | 99 | 17 | CID000000159 |
| Drug | chondroitin sulfate | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 ELN COL1A2 | 1.54e-14 | 413 | 99 | 19 | CID000024766 |
| Drug | AC1L1KMJ | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 ANK2 COL22A1 COL23A1 SCARA5 COL1A2 | 1.60e-14 | 476 | 99 | 20 | CID000030956 |
| Drug | L-3,4-dehydroproline | COL5A1 COL7A1 COL8A1 COL9A3 COL11A1 COL13A1 COL19A1 COL22A1 COL23A1 ELN COL1A2 | 1.69e-14 | 73 | 99 | 11 | CID000094284 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 COL1A2 | 4.71e-13 | 314 | 99 | 16 | CID000447989 |
| Drug | aspirin | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 NOS3 COL1A2 | 3.74e-12 | 563 | 99 | 19 | CID000002244 |
| Drug | Y-27632 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 NOS3 COL1A2 | 8.02e-12 | 444 | 99 | 17 | CID000005711 |
| Drug | LS-63783 | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL19A1 COL22A1 COL23A1 TRPM5 KCNH1 NOS3 COL1A2 | 2.98e-11 | 804 | 99 | 21 | CID000000231 |
| Drug | LMWH | COL4A1 COL4A3 COL4A5 COL4A6 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 COL13A1 COL17A1 COL22A1 COL23A1 ELN NOS3 COL1A2 | 5.03e-10 | 663 | 99 | 18 | CID000000772 |
| Drug | NC-4 | 7.96e-10 | 44 | 99 | 7 | CID006420119 | |
| Drug | 1h00 | 4.62e-09 | 56 | 99 | 7 | CID000445950 | |
| Drug | isodesmosine | 5.84e-09 | 33 | 99 | 6 | CID000013811 | |
| Drug | pyridinoline | 1.19e-08 | 99 | 99 | 8 | CID000105068 | |
| Drug | 1zd2 | 4.12e-08 | 45 | 99 | 6 | CID004149241 | |
| Drug | desmosine | 1.13e-07 | 53 | 99 | 6 | CID000025435 | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.00e-07 | 197 | 99 | 9 | 3848_DN | |
| Drug | NSC-333492 | 3.18e-07 | 4 | 99 | 3 | CID000333256 | |
| Drug | Span 40 | 3.26e-07 | 14 | 99 | 4 | CID000014927 | |
| Drug | dermatan sulfate | COL4A3 COL4A5 COL5A1 COL9A1 COL9A2 COL9A3 COL11A1 COL11A2 ELN | 5.08e-07 | 220 | 99 | 9 | CID000032756 |
| Drug | In2-7 | 1.58e-06 | 6 | 99 | 3 | CID002816385 | |
| Drug | pyrachlostrobin | COL4A1 COL4A5 COL4A6 COL5A1 COL5A2 COL8A1 COL11A1 ITPRIPL2 COL19A1 VASN COL5A3 IRF7 COL22A1 AHNAK | 1.09e-05 | 811 | 99 | 14 | ctd:C513428 |
| Drug | meticrane | 1.28e-05 | 11 | 99 | 3 | CID000004165 | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 1.71e-05 | 186 | 99 | 7 | 1228_UP | |
| Drug | 2,3-pentanedione | 2.14e-05 | 129 | 99 | 6 | ctd:C013186 | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 2.32e-05 | 195 | 99 | 7 | 5388_DN | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 3259_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 6083_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 2269_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.65e-05 | 199 | 99 | 7 | 2071_UP | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.73e-05 | 200 | 99 | 7 | 3935_UP | |
| Drug | PD123177 | 3.64e-05 | 43 | 99 | 4 | CID000114899 | |
| Drug | NOC 18 | 4.29e-05 | 16 | 99 | 3 | ctd:C093285 | |
| Drug | CP-331 | 5.60e-05 | 3 | 99 | 2 | CID000130967 | |
| Drug | 2-(4-((4-(6-methoxy-3-pyridinyl)-5-(4-(trifluoromethoxy)phenyl)-2-thiazolyl)methoxy)-2-methylphenoxy)acetic acid | 7.76e-05 | 52 | 99 | 4 | ctd:C573693 | |
| Drug | diphenylamine-2-carboxylate | 8.22e-05 | 164 | 99 | 6 | CID000004386 | |
| Drug | 351A | 8.62e-05 | 20 | 99 | 3 | CID000122144 | |
| Drug | gold nanoparticles | 9.36e-05 | 243 | 99 | 7 | CID000023985 | |
| Drug | sodium chloride | COL4A3 COL4A5 COL5A1 COL7A1 COL9A1 COL9A2 COL9A3 COL11A1 COL13A1 COL17A1 FCN1 NOS3 COL1A2 | 9.50e-05 | 865 | 99 | 13 | CID000000206 |
| Drug | kalinin | 9.68e-05 | 55 | 99 | 4 | CID000032518 | |
| Drug | Brn 2557402 | 1.12e-04 | 4 | 99 | 2 | CID000042742 | |
| Drug | AC1L9INI | 1.27e-04 | 59 | 99 | 4 | CID000445839 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.64e-04 | 186 | 99 | 6 | 6891_UP | |
| Drug | Pentaerythritol Tetranitrate | 1.86e-04 | 5 | 99 | 2 | ctd:D010417 | |
| Drug | dimethylmalonimidate | 1.86e-04 | 5 | 99 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 1.86e-04 | 5 | 99 | 2 | CID006449872 | |
| Drug | 4-aminoazobenzene | 1.97e-04 | 66 | 99 | 4 | CID000006051 | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 4552_UP | |
| Drug | 2f1b | 2.09e-04 | 67 | 99 | 4 | CID011963508 | |
| Drug | Piromidic acid [19562-30-2]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 3335_UP | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 2770_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 2701_DN | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A | 2.12e-04 | 195 | 99 | 6 | 1884_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 4582_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3639_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3466_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 5746_DN | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 6137_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; HL60; HG-U133A | 2.30e-04 | 198 | 99 | 6 | 1402_UP | |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 3248_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.30e-04 | 198 | 99 | 6 | 3305_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 6069_UP | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 4799_DN | |
| Drug | Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 2564_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.36e-04 | 199 | 99 | 6 | 2292_UP | |
| Drug | fullerene C60 | COL4A2 COL5A1 COL7A1 COL8A1 MAP6 IRF7 GPRIN1 RXRB SH2B1 PRX COL23A1 TTBK2 FCN1 CBY2 ELN BSN NOS3 | 2.36e-04 | 1498 | 99 | 17 | ctd:C069837 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | COL4A1 COL4A5 COL5A1 COL5A2 COL9A1 COL9A2 COL11A1 ELN COL1A2 | 9.94e-14 | 53 | 95 | 9 | C4707243 |
| Disease | collagen disease (implicated_via_orthology) | 2.42e-10 | 12 | 95 | 5 | DOID:854 (implicated_via_orthology) | |
| Disease | Stickler syndrome | 5.03e-10 | 5 | 95 | 4 | cv:C0265253 | |
| Disease | Stickler syndrome (disorder) | 3.23e-08 | 3 | 95 | 3 | C0265253 | |
| Disease | Alport syndrome | 3.23e-08 | 3 | 95 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 3.23e-08 | 3 | 95 | 3 | cv:CN076135 | |
| Disease | 1,5 anhydroglucitol measurement | 3.47e-08 | 29 | 95 | 5 | EFO_0008009 | |
| Disease | Stickler syndrome (is_implicated_in) | 1.29e-07 | 4 | 95 | 3 | DOID:0080046 (is_implicated_in) | |
| Disease | Hematuria, Benign Familial | 1.29e-07 | 4 | 95 | 3 | C0241908 | |
| Disease | Alport Syndrome | 1.29e-07 | 4 | 95 | 3 | C1567741 | |
| Disease | Cleft Palate | 2.54e-07 | 81 | 95 | 6 | C0008925 | |
| Disease | Stickler syndrome, type 1 | 3.22e-07 | 5 | 95 | 3 | C2020284 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 3.22e-07 | 5 | 95 | 3 | cv:CN043640 | |
| Disease | Alport Syndrome, X-Linked | 3.22e-07 | 5 | 95 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 3.22e-07 | 5 | 95 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 3.22e-07 | 5 | 95 | 3 | C1567744 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.77e-07 | 19 | 95 | 4 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 4.70e-07 | 20 | 95 | 4 | C0026760 | |
| Disease | myopathy (implicated_via_orthology) | 4.77e-07 | 48 | 95 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | Hereditary hearing loss and deafness | 4.83e-07 | 146 | 95 | 7 | cv:C0236038 | |
| Disease | Congenital cataract | 6.42e-07 | 6 | 95 | 3 | C0009691 | |
| Disease | Intervertebral disc disorder | 6.42e-07 | 6 | 95 | 3 | C0158252 | |
| Disease | Early Pregnancy Loss | 1.47e-06 | 109 | 95 | 6 | C3830362 | |
| Disease | Spontaneous abortion | 1.47e-06 | 109 | 95 | 6 | C0000786 | |
| Disease | Miscarriage | 1.47e-06 | 109 | 95 | 6 | C4552766 | |
| Disease | Abortion, Tubal | 1.47e-06 | 109 | 95 | 6 | C0000822 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.68e-06 | 9 | 95 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | Disproportionate short stature | 5.12e-06 | 77 | 95 | 5 | C0878659 | |
| Disease | Connective Tissue Diseases | 9.03e-06 | 13 | 95 | 3 | C0009782 | |
| Disease | visceral adipose tissue measurement, body mass index | 9.33e-06 | 87 | 95 | 5 | EFO_0004340, EFO_0004765 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 1.03e-05 | 2 | 95 | 2 | C1839884 | |
| Disease | Ehlers-Danlos syndrome type 1 | 1.03e-05 | 2 | 95 | 2 | C0268335 | |
| Disease | Ehlers-Danlos syndrome type 2 | 1.03e-05 | 2 | 95 | 2 | C0268336 | |
| Disease | Fibrochondrogenesis | 1.03e-05 | 2 | 95 | 2 | C0265282 | |
| Disease | Developmental Porencephaly | 1.03e-05 | 2 | 95 | 2 | C4082301 | |
| Disease | Congenital porencephaly | 1.03e-05 | 2 | 95 | 2 | C0302892 | |
| Disease | Alport syndrome, recessive type | 1.03e-05 | 2 | 95 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 1.03e-05 | 2 | 95 | 2 | C2931253 | |
| Disease | PORENCEPHALY, FAMILIAL | 1.03e-05 | 2 | 95 | 2 | C1867983 | |
| Disease | Ehlers-Danlos syndrome classic type | 1.03e-05 | 2 | 95 | 2 | C4225429 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 1.03e-05 | 2 | 95 | 2 | C0403440 | |
| Disease | Porencephaly, Type 1, Autosomal Dominant | 1.03e-05 | 2 | 95 | 2 | C4551998 | |
| Disease | Stickler syndrome (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0080046 (implicated_via_orthology) | |
| Disease | benign familial hematuria (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Post-traumatic Porencephaly | 1.03e-05 | 2 | 95 | 2 | C3698507 | |
| Disease | Porencephaly | 1.03e-05 | 2 | 95 | 2 | C4082173 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 1.03e-05 | 2 | 95 | 2 | C3281105 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 1.03e-05 | 2 | 95 | 2 | C4746745 | |
| Disease | Ehlers-Danlos syndrome, classic type | 1.03e-05 | 2 | 95 | 2 | cv:C4225429 | |
| Disease | Benign familial hematuria | 1.03e-05 | 2 | 95 | 2 | cv:C0241908 | |
| Disease | Leiomyoma, Epithelioid | 1.03e-05 | 2 | 95 | 2 | C0086533 | |
| Disease | Blood Coagulation Disorders | 1.76e-05 | 16 | 95 | 3 | C0005779 | |
| Disease | Osteochondrodysplasias | 3.02e-05 | 19 | 95 | 3 | C0029422 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 3.07e-05 | 3 | 95 | 2 | C4552122 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome (is_implicated_in) | 3.07e-05 | 3 | 95 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 3.07e-05 | 3 | 95 | 2 | C0220679 | |
| Disease | Ehlers-Danlos syndrome classic type 1 (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:14720 (implicated_via_orthology) | |
| Disease | Hemorrhage, intracerebral, susceptibility to | 3.07e-05 | 3 | 95 | 2 | cv:C3281105 | |
| Disease | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 3.07e-05 | 3 | 95 | 2 | 614519 | |
| Disease | pulse pressure measurement | COL4A1 COL8A1 RIN3 COL11A1 ANK2 VASN PCDHAC1 PCDHA12 PCDHA10 PCDHA5 PCDHA2 COL23A1 FAM193A ELN C1QTNF7 | 3.74e-05 | 1392 | 95 | 15 | EFO_0005763 |
| Disease | Liver Cirrhosis, Experimental | COL4A1 COL4A2 COL5A1 COL5A2 ZBTB4 FCN1 AHNAK ROBO2 ALDH2 NOS3 COL1A2 | 3.98e-05 | 774 | 95 | 11 | C0023893 |
| Disease | Renal glomerular disease | 5.46e-05 | 23 | 95 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 5.46e-05 | 23 | 95 | 3 | C4521256 | |
| Disease | essential hypertension (implicated_via_orthology) | 6.13e-05 | 4 | 95 | 2 | DOID:10825 (implicated_via_orthology) | |
| Disease | Lumbar disc disease | 1.02e-04 | 5 | 95 | 2 | C0221775 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 1.02e-04 | 5 | 95 | 2 | 603932 | |
| Disease | Intervertebral disc disorder | 1.02e-04 | 5 | 95 | 2 | cv:C0158252 | |
| Disease | waist-hip ratio | COL4A1 COL4A2 COL5A1 COL8A1 COL9A3 COL11A1 VASN COL5A3 SH2B1 AHNAK SYNE2 C1QTNF7 MAPKBP1 | 1.52e-04 | 1226 | 95 | 13 | EFO_0004343 |
| Disease | aortic valve disease (implicated_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:62 (implicated_via_orthology) | |
| Disease | hypertensive nephropathy | 1.53e-04 | 6 | 95 | 2 | C0848548 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 2.13e-04 | 7 | 95 | 2 | C1846545 | |
| Disease | Bleeding tendency | 2.13e-04 | 7 | 95 | 2 | C1458140 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 2.72e-04 | 39 | 95 | 3 | EFO_0008298 | |
| Disease | Ehlers-Danlos syndrome | 2.84e-04 | 8 | 95 | 2 | cv:C0013720 | |
| Disease | end stage renal disease (is_implicated_in) | 3.15e-04 | 41 | 95 | 3 | DOID:783 (is_implicated_in) | |
| Disease | Abnormality of refraction | COL4A3 COL5A1 SPI1 ZBTB4 PCDHAC1 PCDHA12 PCDHA10 PCDHA5 PCDHA2 | 3.25e-04 | 673 | 95 | 9 | HP_0000539 |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 3.64e-04 | 9 | 95 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Hematuria | 3.64e-04 | 9 | 95 | 2 | C0018965 | |
| Disease | Sensory hearing loss | 5.54e-04 | 11 | 95 | 2 | C1691779 | |
| Disease | vital capacity | COL8A1 RIN3 ZBTB4 PCDHAC1 PCDHA12 PCDHA10 PCDHA5 PCDHA2 SH2B1 ALDH2 MAPKBP1 COL1A2 | 6.12e-04 | 1236 | 95 | 12 | EFO_0004312 |
| Disease | Disorder of eye | 6.26e-04 | 212 | 95 | 5 | C0015397 | |
| Disease | intracranial aneurysm (is_implicated_in) | 6.63e-04 | 12 | 95 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Small cell carcinoma of lung | 7.12e-04 | 54 | 95 | 3 | C0149925 | |
| Disease | neutrophil count, basophil count | 8.02e-04 | 224 | 95 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | Tinnitus | 8.40e-04 | 130 | 95 | 4 | HP_0000360 | |
| Disease | osteoarthritis (implicated_via_orthology) | 1.05e-03 | 15 | 95 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 1.07e-03 | 62 | 95 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | parental longevity | 1.10e-03 | 494 | 95 | 7 | EFO_0007796 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.20e-03 | 16 | 95 | 2 | C0038015 | |
| Disease | atherosclerosis (is_implicated_in) | 1.20e-03 | 16 | 95 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.20e-03 | 16 | 95 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.20e-03 | 16 | 95 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.20e-03 | 16 | 95 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.20e-03 | 16 | 95 | 2 | C0025237 | |
| Disease | stroke | 1.23e-03 | 144 | 95 | 4 | EFO_0000712 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 1.35e-03 | 17 | 95 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Necrotizing Enterocolitis | 1.35e-03 | 17 | 95 | 2 | C0520459 | |
| Disease | Van Buchem disease | 1.35e-03 | 17 | 95 | 2 | C0432272 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGIKGEPGAPGKIVT | 796 | Q9UMD9 | |
| LPPGKGEEGPGPELH | 86 | Q5SQH8 | |
| KGDPGLPGLDGITGP | 171 | Q14031 | |
| VIGEPGKDGVPGLPG | 571 | Q14031 | |
| GKPGEAGLPGLPGVD | 71 | Q14050 | |
| VPGITGKPGVPGKEA | 506 | Q14050 | |
| GIPGVDGPKGEPGLL | 461 | Q01955 | |
| GLDGIPGTPGVKGLP | 566 | Q01955 | |
| KEAGFPPGVVNIVPG | 221 | P47895 | |
| GPVGIPGLKGERGDP | 1201 | P53420 | |
| KGDIGVPGIPGLPGF | 1036 | P08572 | |
| AGPAVPGGLPKDALA | 116 | A6QL63 | |
| PEVDIEGPEGKLKGP | 4491 | Q09666 | |
| PKIKGDVPSVGLEGP | 5206 | Q09666 | |
| PLPGLEEKPPGVGTS | 976 | Q9BXF3 | |
| SGEPPGAPKEDGVLG | 366 | P78312 | |
| EKGEAGPPGPPGIVI | 321 | P02462 | |
| PGIVIGTGPLGEKGE | 331 | P02462 | |
| GLPGIPGTPGEKGSI | 746 | P02462 | |
| PYDIIKGEPGLPGPE | 1351 | P02462 | |
| ALEGVLPGLGPPLGM | 181 | O95158 | |
| VGPEPLGPESQSGKG | 211 | Q9Y3T6 | |
| QSGPGELPDKFIIPG | 876 | Q9Y5H9 | |
| LGPPGTKFLGPVIVE | 1066 | Q01484 | |
| EPSIGVNGGPLKPEI | 26 | Q0GE19 | |
| RGPSKGEAGVEGPPL | 1101 | Q8WXD9 | |
| GEPTGPILGAEALPG | 1106 | P78559 | |
| PGGLVPPGGKTFIVV | 401 | Q9BXT6 | |
| GPLAAGLGPLVPGKV | 131 | O15525 | |
| GEGPIVPAPVKDEGP | 616 | Q96JE9 | |
| DIKDGGLFPPPLSVG | 96 | Q8IYA8 | |
| LAGPPGPELPVAGEK | 556 | Q9BQS8 | |
| EELLGPPAPGDKGSG | 331 | P50219 | |
| SIGLKPGPVPEPGAE | 1826 | Q9UPA5 | |
| GKEPGEPGVLDGPTL | 3266 | Q9UPA5 | |
| GLIGLIGPPGEQGEK | 1456 | P12107 | |
| LGLPGAPGIDGEKGP | 341 | Q86Y22 | |
| VGPPGLIGLPGTKGE | 456 | Q86Y22 | |
| PGIQGEPGVKGPRGE | 1221 | P13942 | |
| GKIGFADQIPPPLEG | 326 | O95259 | |
| PPDTLGGAEAGPKGL | 81 | Q86UY5 | |
| VPTKAPGEGQEGLPL | 206 | Q92985 | |
| GPGELPDKFIIPGSP | 866 | Q9Y5H7 | |
| VGEVALPGQGGLPKE | 196 | Q9NZU5 | |
| PVAVEQLEKGSPGGP | 826 | P29474 | |
| QSGPGELPDKFIIPG | 876 | Q9Y5I2 | |
| GAGGLEPGPLPEDVF | 281 | P14652 | |
| QSGPGELPDKFIIPG | 891 | Q9H158 | |
| APELPEGILKGGSLP | 646 | Q3KR16 | |
| LPGAPGPKGEAGVIG | 56 | O00602 | |
| GPSGEEEAKVGPGLP | 336 | Q8NA61 | |
| GGTLEKPPPGEGVTL | 81 | Q8IYK2 | |
| PAGKEGPVGLPGIDG | 461 | P08123 | |
| AGQDGKPPGDVLVGP | 401 | Q0VDD7 | |
| PRGPVGIGVQGPKGE | 491 | Q2UY09 | |
| IKGEKGDPGGIIGPP | 556 | Q14993 | |
| PGGPSEGKLIPGDQI | 106 | Q14CM0 | |
| EPPGVVGGPGEKAKP | 141 | Q86SF2 | |
| VGGPGEKAKPLVLGP | 146 | Q86SF2 | |
| AGGGDLLLPPSPKVE | 1981 | Q5TH69 | |
| IPGEKGDPGPPGLDV | 841 | P29400 | |
| PVGLPGEIGIRGPKG | 126 | Q14055 | |
| QGPEGKLGPLGAPGE | 581 | P05997 | |
| LGPRGEKGPIGAPGI | 371 | P27658 | |
| GPPGEQGLPGLAGKE | 1021 | P20908 | |
| GLPGPPGEKGETGDV | 1231 | P20908 | |
| GEAGLEGPPGKTGPI | 1411 | P20908 | |
| GLIGLIGPPGEQGEK | 1486 | P20908 | |
| GPKGDIGAIGPVGAP | 496 | Q8NFW1 | |
| IGAIGPVGAPGPKGE | 501 | Q8NFW1 | |
| GEPGELGEPGLPGEV | 551 | Q8NFW1 | |
| GEKGDPGLPGEPGLQ | 871 | Q8NFW1 | |
| GPSGLPGIPGEEGKE | 1231 | Q8NFW1 | |
| APGEAEKPGFPVGLG | 1321 | O60336 | |
| GLPGVPGIPGAKGVA | 571 | P20849 | |
| GEKGEPGRPGDPAVV | 1531 | Q02388 | |
| DPAVVGPAVAGPKGE | 1541 | Q02388 | |
| GPKVSVDEPGPGLSG | 2091 | Q02388 | |
| EIGLPGPPGHDGEKG | 486 | Q5TAT6 | |
| AGEKGNPGAEVPGLP | 556 | Q5TAT6 | |
| EPEILGKGDPVAPGR | 186 | Q7Z2K8 | |
| EGGVLTLPPVDGLPG | 751 | Q9NZ56 | |
| LAPGVGVAPGVGVAP | 526 | P15502 | |
| DEGKEGRPGIPGLPG | 316 | Q6ZMJ2 | |
| IGPEGEKGEVGPIGP | 106 | Q9BXJ2 | |
| GPVGLPGHPGLKGEE | 491 | P25940 | |
| GLPGPPGEKGEVGDV | 1151 | P25940 | |
| EKGHIGLIGLIGPPG | 1401 | P25940 | |
| GLIGLIGPPGEAGEK | 1406 | P25940 | |
| KGLEEGPAPVLPTGQ | 506 | Q9P2P1 | |
| GPGELPDKFIIPGSP | 871 | Q9UN75 | |
| GDPTGPVPVVGKGEE | 11 | Q8TB24 | |
| LGPGGAAAEVGPLPK | 456 | Q3MIP1 | |
| PGDDLGKGGVVIAIP | 191 | Q14D33 | |
| PGAEGPLLGVHGIPK | 1071 | Q5T011 | |
| EKAGGGGVPEELVPV | 681 | Q9NRF2 | |
| AVGIGKGDALPPPTL | 21 | Q9BT43 | |
| KLVGVVPGPVGEPAD | 206 | Q9HA77 | |
| LPPGTDGGKEGPRVL | 6496 | Q8WXH0 | |
| DGLEPGPGLLPGETG | 151 | P17947 | |
| EAVPGGPGREPEGLL | 361 | P0CW24 | |
| VSLPGGGSGPPEDVK | 166 | P28702 | |
| PPEPEGGGEEKVVGM | 501 | Q8TE77 | |
| LPEGPVPEGAGLKGH | 1396 | Q8IVF2 | |
| LPEGPVPEGAGLKGH | 2386 | Q8IVF2 | |
| LPEGPVPEGAGLKGH | 2551 | Q8IVF2 | |
| KEAGFPPGVVNIVPG | 226 | P05091 | |
| VVPGLPALAPAKPGG | 681 | Q9H2X0 | |
| LVFIEEPPGGGGVAP | 106 | Q9NRU3 | |
| EEGPLAGGPGLQEPL | 26 | Q8N1B4 | |
| GGPPLEGVGPFREKT | 1281 | Q9H9J4 | |
| PELQPLLEGEVKGGP | 636 | P38435 | |
| LLEGEVKGGPEPTPL | 641 | P38435 | |
| GLVPPKEIGEPQEGP | 66 | Q9C0A1 | |
| VEPGPPGKGDGLTEL | 186 | Q9NZQ8 | |
| SIPGKEPPLGGLVDS | 341 | P98077 | |
| GGEQPPPGAKEGLEV | 321 | Q8WVR3 | |
| PPPTAGKFVVVGGGI | 6 | Q8WU10 | |
| GKVDPGLGGPLVPDL | 186 | O95630 | |
| GIGVSGPEVKVPKGP | 426 | Q9BXM0 | |
| ENGIPVGVSPDKLPG | 356 | Q6IQ55 | |
| PPIPPKGEGERAGVE | 991 | Q9P1Z0 | |
| PGGRSGGPEPILLEE | 456 | Q9H3T2 | |
| GDVLPPVPGQGDKTA | 951 | Q9HCK4 | |
| LGPEKLLDGPPGVDV | 1446 | O95359 | |
| GPGAGPLELEGVKVP | 616 | Q6EMK4 | |
| GVKVPLEPGPKATEG | 626 | Q6EMK4 | |
| LVSLGVGPAGPKPGV | 71 | Q8IZ26 | |
| VGPAGPKPGVISQLE | 76 | Q8IZ26 | |
| KGGGPPREDVGAPLV | 806 | Q9P206 |